Amniotic Fluid Embolism

Complex MONDO:0850046 Pathograph 45 Show in embeddings browser Pregnancy disorder Obstetric emergency Peripartum cardiovascular collapse

Amniotic fluid embolism is a rare peripartum syndrome of sudden respiratory compromise, cardiovascular collapse and coagulopathy. Presentation and timing vary with the case definition; cardiac arrest occurs in many, but not all, cases. Abnormal maternal inflammatory responses to material from the fetal compartment are proposed, but the initiating exposure, susceptibility factors and causal mediator sequence remain unresolved. Pulmonary hypertension and acute right ventricular dysfunction can reduce systemic blood flow; left ventricular dysfunction and pulmonary edema may follow. Coagulation activation and excessive fibrinolysis contribute to severe bleeding, without establishing that thrombosis is absent. Diagnosis remains clinical, with urgent exclusion of alternative causes of maternal collapse. Treatment centers on resuscitation, hemodynamic and respiratory support, correction of bleeding and coagulopathy, and resuscitative delivery when indicated.

Ask OpenScientist

Ask a research question about Amniotic Fluid Embolism. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

20
Pathophys.
2
Histopath.
21
Phenotypes
1
Hypotheses
6
Gaps
45
Pathograph
13
Medical Actions
6
Differentials
23
References
◈

Mechanistic Hypotheses

1
Abnormal maternal inflammatory response to fetal-compartment exposure
maternal_inflammatory_response CANONICAL
Evidence balance 2 support
A prevailing explanatory model links fetal-compartment material entering maternal blood to inflammatory mediator activation. Neither a specific antigen nor an IgE-independent pathway has been established for every clinical presentation. Complement, mast-cell and cytokine observations are heterogeneous and do not prove an obligatory sequence.
Pathograph links
Maternal-Fetal Barrier Disruption -> Fetal Material Entry into Maternal Circulation INDIRECT UNKNOWN INTERMEDIATES Disruption may permit transfer; the initiating route is inferred.
Fetal Material Entry into Maternal Circulation -> Maternal Inflammatory Mediator Activation INDIRECT UNKNOWN INTERMEDIATES The inflammatory response to fetal material is proposed, without a proven specific antigen or universal pathway.
Fetal Material Entry into Maternal Circulation -> Coagulation Cascade Activation INDIRECT UNKNOWN INTERMEDIATES Amniotic components and inflammatory activation can initiate coagulation in the proposed model; clinical antigen assays do not identify the initiating activity.
Fetal Material Entry into Maternal Circulation -> Complement Activation INDIRECT UNKNOWN INTERMEDIATES Complement activation is proposed following exposure, but its initiating pathway is unresolved.
Maternal Inflammatory Mediator Activation -> Pulmonary Vasoconstriction INDIRECT UNKNOWN INTERMEDIATES Inflammatory mediators are proposed to provoke vasospasm; disease-specific mediators remain unresolved.
Maternal Inflammatory Mediator Activation -> Impaired Pulmonary Gas Exchange INDIRECT UNKNOWN INTERMEDIATES Inflammation-associated lung injury is a proposed additional respiratory route, not a fully resolved cellular mechanism.
Complement Activation -> Maternal Inflammatory Mediator Activation INDIRECT UNKNOWN INTERMEDIATES Complement may amplify inflammation; low concentrations alone do not establish this bridge.
Complement Activation -> Pulmonary Mast Cell Degranulation UNKNOWN Complement-induced degranulation is an unresolved proposed route; neither direction nor necessity is established.
Reduced C1 Esterase Inhibitor Activity -> Complement Activation INDIRECT UNKNOWN INTERMEDIATES Reduced inhibitory activity might permit greater complement activation; causal direction is unproven.
Show evidence (2 references)
PMID:24402585 SUPPORT REVIEW SYNTHESIS Other
"The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition."
PMID:24865116 SUPPORT REVIEW SYNTHESIS Other
"To date, immunological mechanisms, amniotic fluid-dependent anaphylactic reaction and complement activation, have been proposed as potential pathogenetic and pathophysiological mechanisms."
?

Discussions and Knowledge Gaps

6
How do case definitions affect mechanistic and outcome estimates?
KNOWLEDGE GAP OPEN afe_case_definition
Strict research criteria improve consistency but exclude some expert-adjudicated atypical cases. The 2020 voluntary registry classified 59/129 typical, 15 atypical, 27 alternative and 28 indeterminate; indeterminate does not mean a proven alternative diagnosis. A 2024 series selected 29 cases using broader proposed criteria, none meeting Clark criteria, without a gold-standard validation of the new definition. Different ascertainment and incomplete records limit pooled frequency and mortality interpretations.
Show evidence (2 references)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"22% (28/129) had an uncertain diagnosis."
PMID:38082418 SUPPORT PRIMARY RESULT Human Clinical
"None of the cases met Clark's criteria while all met our criteria."
Which immune observations are causal rather than accompanying critical illness?
CONTROVERSY OPEN afe_complement_and_mast_cells
Attached to
pathophysiology#Complement Activation pathophysiology#Reduced C1 Esterase Inhibitor Activity pathophysiology#Pulmonary Mast Cell Degranulation pathophysiology#Maternal Inflammatory Mediator Activation
Low C1 inhibitor activity and complement concentrations, pulmonary degranulation and occasional cytokine elevations supply hypotheses rather than an established ordered pathway. Serum and tissue tryptase measurements sample different compartments and times; negative serum findings in other cases do not refute local lung degranulation. Healthy controls alone do not resolve specificity against sepsis, anaphylaxis or hemorrhagic shock.
Show evidence (2 references)
PMID:25807263 SUPPORT REVIEW SYNTHESIS Human Clinical
"the results obtained were negative for serum tryptase and urinary histamine measurements in women with AFE"
PMID:41765067 SUPPORT BACKGROUND Human Clinical
"It is not known whether C1-INH dysregulation precedes clinical deterioration or reflects downstream consumption"
What can the coagulation comparison establish?
INTERPRETATION OPEN afe_coagulation_scope
Attached to
pathophysiology#Coagulation Cascade Activation pathophysiology#Excessive Plasmin Generation pathophysiology#Reduced Functional Fibrinogen
The 27 AFE samples were selected from 789 registry cases meeting Erez DIC criteria among 2059 reports. Sampling was before transfusion but after a median 4.9 L blood loss and 1.3 L administered fluid, with variable timing. Both thrombin-generation and plasmin-generation markers were elevated. A nonsignificant within-group correlation does not establish coagulation-independent fibrinolysis. Antigen assays do not quantify tPA or TAFIa activity. The graph represents coagulation activation and excessive fibrinolysis without asserting that occlusive microthrombi cannot form.
Show evidence (2 references)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"Among a total of 2059 cases enrolled in the Japanese AFE Registry, we identified 789 AFE patients who met the definition of DIC by Erez’s diagnostic criteria. Of these, plasma samples before blood transfusion were available for 27 cases."
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"We evaluated antigen levels, not activity, for the plasma tPA and total TAFI"
Do epidemiologic associations justify altering obstetric practice?
INTERPRETATION OPEN afe_risk_association
Population studies report associations with medical induction, advanced maternal age and placental or delivery complications. These do not identify a deterministic cause; confounding, reverse causation and case misclassification remain possible. Absence of an actionable prevention rule does not refute an association. The Canadian three-million-delivery study reported adjusted odds 1.8 for medical induction with low absolute excess risk. Current clinical assessment should follow indications for obstetric care rather than an unvalidated AFE prevention strategy.
Show evidence (2 references)
PMID:17055946 SUPPORT PRIMARY RESULT Human Clinical
"Medical induction of labour nearly doubled the risk of overall cases of amniotic-fluid embolism (adjusted odds ratio 1.8 [1.3-2.7])"
PMID:24402585 SUPPORT REVIEW SYNTHESIS Other
"at present, no putative risk factor has been identified that would justify modification of standard obstetric practice to reduce the risk of this condition."
What is known about long-term recovery and subsequent pregnancy?
INTERPRETATION OPEN afe_survivorship
Selected registry interviews at least one year after AFE found PTSD-consistent symptoms in 16/29 available survivors; this is not a population PTSD diagnosis rate. Seven women reported a later pregnancy: one miscarriage and six uncomplicated term births without recurrence. These small selected observations support follow-up and individualized counseling, not a claim of zero recurrence risk. The Australasian surveillance captured initial management rather than long-term neurologic outcomes.
Show evidence (2 references)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"Of 29 survivors available for interview, 2 reported thyroid abnormalities, 1 reported persistent liver dysfunction, and 16 (55.1%) endorsed symptoms consistent with PTSD"
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"Seven women who experienced either typical or atypical AFE had a subsequent pregnancy: 1 miscarried, and the other 6 had an uncomplicated pregnancy and delivered at term with no recurrence of AFE."
Does fetal material cause collapse through pulmonary microvascular obstruction?
CONTROVERSY OPEN afe_mechanical_hypothesis
Mechanical obstruction was the historical explanation and remains discussed in older pathology accounts. Detection of fetal material does not quantify occlusion or establish causality. The 2026 SMFM statement considers a direct embolic explanation unlikely; the initiating inflammatory trigger remains unresolved. This entry therefore does not assert an established mechanical-obstruction node.
Show evidence (2 references)
PMID:24888909 SUPPORT REVIEW SYNTHESIS Other
"the fetal materials create physical obstructions in the maternal microvessels in various organs, such as the lung"
Older review interpretation, not a new quantitative obstruction experiment.
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Despite its name, AFE likely has no direct relation to either amniotic fluid or an embolism"
⚙

Pathophysiology

20
Maternal-Fetal Barrier Disruption
Disruption at the placental interface, cervical veins or uterine injury may permit transfer of fetal-compartment material. These routes are proposed triggers; a specific breach is not demonstrated in every affected patient.
Abnormal maternal inflammatory response to fetal-compartment exposure
Downstream
Fetal Material Entry into Maternal Circulation Disruption may permit transfer; the initiating route is inferred. Abnormal maternal inflammatory response to fetal-compartment exposure
Show evidence (1 reference)
PMID:24402585 SUPPORT REVIEW SYNTHESIS Other
"The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition."
Fetal Material Entry into Maternal Circulation
Entry of fetal-compartment material is a proposed initiating exposure. Detection of squamous cells alone neither establishes AFE nor proves obstructive embolization; such cells can occur without the syndrome.
Abnormal maternal inflammatory response to fetal-compartment exposure
Downstream
Maternal Inflammatory Mediator Activation The inflammatory response to fetal material is proposed, without a proven specific antigen or universal pathway. Abnormal maternal inflammatory response to fetal-compartment exposure
Coagulation Cascade Activation Amniotic components and inflammatory activation can initiate coagulation in the proposed model; clinical antigen assays do not identify the initiating activity. Abnormal maternal inflammatory response to fetal-compartment exposure
Complement Activation Complement activation is proposed following exposure, but its initiating pathway is unresolved. Abnormal maternal inflammatory response to fetal-compartment exposure
Show evidence (2 references)
PMID:24402585 SUPPORT REVIEW SYNTHESIS Other
"The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition."
PMID:33345954 SUPPORT BACKGROUND Human Clinical
"Continued erroneous reliance on the detection of squamous cells in the pulmonary circulation as a pathognomonic criterion for AFE diagnosis regardless of clinical presentation also plays a role in erroneous diagnoses."
Maternal Inflammatory Mediator Activation
An abnormal inflammatory response is a leading model. A 2026 reanalysis found markedly elevated IL-6, IL-8 and IL-10 in two banked samples from one fatal clinically diagnosed case, including admission before overt collapse. Fever developed after epidural analgesia, no autopsy was performed, and microbial versus sterile triggers were unresolved. The observation does not establish a universal fetal-antigen trigger, a prediction test, or efficacy of immunomodulation.
Abnormal maternal inflammatory response to fetal-compartment exposure
Downstream
Pulmonary Vasoconstriction Inflammatory mediators are proposed to provoke vasospasm; disease-specific mediators remain unresolved. Abnormal maternal inflammatory response to fetal-compartment exposure
Impaired Pulmonary Gas Exchange Inflammation-associated lung injury is a proposed additional respiratory route, not a fully resolved cellular mechanism. Abnormal maternal inflammatory response to fetal-compartment exposure
Show evidence (2 references)
PMID:24402585 SUPPORT REVIEW SYNTHESIS Other
"This response and its subsequent injury appear to involve activation of proinflammatory mediators similar to that seen with the classic systemic inflammatory response syndrome."
PMID:41765067 SUPPORT PRIMARY RESULT Human Clinical
"The admission plasma sample, obtained when the patient appeared completely asymptomatic, showed extraordinary elevations of key inflammatory cytokines relative to women in labor."
Single-case observation against six term-labor and six term-not-in-labor controls.
Complement Activation
Reduced C3 and C4 concentrations in small clinical series are compatible with complement activation, but concentrations alone do not identify the pathway, prove consumption or establish its causal role. Normal labor also changes complement measurements.
Abnormal maternal inflammatory response to fetal-compartment exposure
complement activation GO:0006956 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased complement activation (GO:0006956). GO:0006956 is a biological process from the Gene Ontology.
Downstream
Maternal Inflammatory Mediator Activation Complement may amplify inflammation; low concentrations alone do not establish this bridge. Abnormal maternal inflammatory response to fetal-compartment exposure
Pulmonary Mast Cell Degranulation Complement-induced degranulation is an unresolved proposed route; neither direction nor necessity is established. Abnormal maternal inflammatory response to fetal-compartment exposure
Show evidence (1 reference)
PMID:24865116 SUPPORT REVIEW SYNTHESIS Other
"To date, immunological mechanisms, amniotic fluid-dependent anaphylactic reaction and complement activation, have been proposed as potential pathogenetic and pathophysiological mechanisms."
Reduced C1 Esterase Inhibitor Activity
A retrospective Japanese registry study measured lower activity in 106 AFE cases than in 88 uncomplicated deliveries and lower values in 21 fatal than 85 nonfatal cases. This is an association, not proof that reduced activity precedes collapse or results from consumption; prognostic utility and replacement efficacy remain unvalidated.
Abnormal maternal inflammatory response to fetal-compartment exposure
Downstream
Complement Activation Reduced inhibitory activity might permit greater complement activation; causal direction is unproven. Abnormal maternal inflammatory response to fetal-compartment exposure
Show evidence (1 reference)
PMID:24561565 SUPPORT PRIMARY RESULT Human Clinical
"C1 esterase inhibitor activity levels were significantly lower in amniotic fluid embolism patients (30.0% ± 1.8%) than in control women (62.0% ± 2.0%) (p < 0.0001)."
Pulmonary Mast Cell Degranulation
Extracellular tryptase and mast-cell observations in selected fatal cases support local pulmonary degranulation. Negative or inconsistent serum tryptase and urinary histamine results in other samples constrain a systemic biomarker claim, but do not refute tissue degranulation. Necessity and causal contribution remain unresolved.
mast cell CL:0000097 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves mast cell (CL:0000097). CL:0000097 is a cell type from the Cell Ontology.
mast cell degranulation GO:0043303 ↑ INCREASED Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased mast cell degranulation (GO:0043303). GO:0043303 is a biological process from the Gene Ontology.
Show evidence (1 reference)
PMID:25807263 SUPPORT REVIEW SYNTHESIS Human Clinical
"These studies, therefore, highlight that mast cell degranulation occurs in the lungs of AFE fatal cases, whereas it does not occur in other fatal pregnancies."
Review synthesis of selected autopsy series, not proof of specificity across all causes of death.
Pulmonary Vasoconstriction
Pulmonary vasoconstriction is proposed to raise vascular resistance during acute cardiopulmonary AFE. The responsible mediators and their contributions vary and have not been resolved by the clinical observations.
Downstream
Acute Pulmonary Hypertension Vasoconstriction increases pulmonary vascular resistance and can elevate pressure.
Show evidence (1 reference)
PMID:24888909 SUPPORT REVIEW SYNTHESIS Other
"the liquids cause an anaphylactoid reaction that leads to pulmonary vasospasm and activation of platelets, white blood cells and/or complements."
Acute Pulmonary Hypertension
A rise in pulmonary vascular pressure increases right ventricular afterload. This is a clinically recognized hemodynamic pattern, rather than an obligatory finding in every AFE definition.
Downstream
Acute Right Ventricular Failure Increased pulmonary afterload can precipitate right ventricular failure.
Show evidence (1 reference)
PMID:35840499 SUPPORT REVIEW SYNTHESIS Other
"causing increasing pulmonary vasoconstriction, pulmonary hypertension, acute right ventricular (RV) failure"
Acute Right Ventricular Failure
Acute right ventricular dilation and systolic impairment may occur during the initial collapse. Echocardiography guides recognition and support; this does not establish a universal fixed sequence in all patients.
Downstream
Impaired Left Ventricular Filling Right ventricular dilation can displace the septum and reduce left-sided filling.
Show evidence (1 reference)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Human Clinical
"the pulmonary hypertension and right ventricular dysfunction that commonly characterize AFE"
Impaired Left Ventricular Filling
Right ventricular dilation and leftward septal displacement can impair left ventricular filling and systemic output. This mechanical consequence is distinct from intrinsic left ventricular contractile dysfunction.
Downstream
Reduced Systemic Perfusion Reduced left-sided filling diminishes systemic output.
Show evidence (1 reference)
PMID:35840499 SUPPORT REVIEW SYNTHESIS Other
"interventricular septum displacement to the left thus decreasing left-sided cardiac output."
Left Ventricular Contractile Dysfunction
Left ventricular systolic dysfunction can develop after the initial insult. Myocardial hypoxia and circulating depressant effects have been proposed, but the relative contribution and temporal sequence are not resolved for each patient.
Downstream
Reduced Systemic Perfusion Contractile dysfunction lowers systemic output.
Pulmonary Edema Formation Left ventricular failure can produce hydrostatic pulmonary edema.
Show evidence (1 reference)
PMID:35840499 SUPPORT REVIEW SYNTHESIS Other
"The third stage then follows with LV failure secondary to impaired LV filling, ischaemic injury to the myocardium, myocardial depressant effect (from amniotic fluid), and hypoxaemia from severe ventilation-perfusion mismatching in the lungs"
The source presents a proposed staged model, not serial proof of an obligatory sequence.
Reduced Systemic Perfusion
Reduced cardiac output and, in bleeding cases, loss of circulating volume compromise maternal organ perfusion. Shock and cardiac arrest can result; the clinical presentation need not pass through every proposed cardiac phase.
Downstream
Maternal Tissue Oxygen Deprivation Reduced blood flow compromises tissue oxygen delivery.
Fetal Oxygen Deprivation Maternal circulatory failure can compromise a fetus still in utero.
Profound Hypotension Reduced systemic output can manifest as hypotension.
Cardiac Arrest Severe hemodynamic failure can culminate in arrest.
Show evidence (1 reference)
PMID:35840499 SUPPORT REVIEW SYNTHESIS Other
"further haemodynamic instability, metabolic acidosis, and eventual multiorgan dysfunction and failure."
Pulmonary Edema Formation
Pulmonary edema may have hydrostatic and permeability-related contributions during AFE and subsequent critical illness. Left ventricular failure, inflammatory lung injury and resuscitation-related fluid overload should not be treated as interchangeable or universally present.
Downstream
Impaired Pulmonary Gas Exchange Edema impairs pulmonary oxygen transfer.
Pulmonary Oedema The mechanism corresponds to the clinical edema finding.
Show evidence (1 reference)
PMID:35840499 SUPPORT REVIEW SYNTHESIS Other
"aggravating LV failure and causing cardiogenic pulmonary oedema and further increasing the severity of hypoxaemia."
Impaired Pulmonary Gas Exchange
Severe ventilation-perfusion mismatch and edema impair oxygenation and may produce respiratory failure. Hypoxemia also worsens myocardial oxygen supply and systemic oxygen delivery.
Downstream
Left Ventricular Contractile Dysfunction Hypoxemia can impair myocardial function; this is one of several proposed contributors.
Maternal Tissue Oxygen Deprivation Reduced arterial oxygenation compromises tissue oxygen delivery.
Fetal Oxygen Deprivation Maternal hypoxemia can reduce fetal oxygen delivery.
Acute Hypoxaemia Impaired oxygen transfer manifests as hypoxemia.
Dyspnoea Respiratory compromise can manifest as dyspnea.
Cyanosis Severe arterial desaturation can produce cyanosis.
Respiratory Failure Requiring Ventilatory Support Severe gas-exchange failure can require ventilation.
Show evidence (1 reference)
PMID:35840499 SUPPORT REVIEW SYNTHESIS Other
"hypoxaemia from severe ventilation-perfusion mismatching in the lungs"
Coagulation Cascade Activation
Elevated prothrombin fragment 1+2 supports thrombin generation in selected AFE patients with DIC. The Japanese comparison included 27 pretransfusion samples selected from 789 DIC cases among 2059 registry reports; it does not establish DIC frequency in unselected AFE or identify the initiating tissue-factor activity.
Downstream
Excessive Plasmin Generation Fibrin formation can recruit fibrinolysis; additional activation routes are possible, but the correlation study cannot determine independence.
Reduced Functional Fibrinogen Consumption during activated coagulation is one possible contributor to reduced functional fibrinogen.
Disseminated Intravascular Coagulation Coagulation activation contributes to the clinical coagulopathy syndrome.
Thrombocytopenia Platelet consumption can contribute to thrombocytopenia, but the measured deficit has multiple possible contributors.
Show evidence (1 reference)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"PF1 + 2 and PIC levels were higher in the AFE and sPA groups compared to the control group; however, there was no significant difference between the AFE and sPA groups"
Excessive Plasmin Generation
Elevated plasmin–antiplasmin complexes and fibrin degradation markers support excessive fibrinolysis in selected coagulopathic cases. The absence of a significant PF1+2–PIC correlation within 27 AFE samples does not prove independence from coagulation or a difference from the comparator correlation. Samples followed variable blood loss and fluid administration.
Downstream
Reduced Functional Fibrinogen Fibrinogen degradation and interference with polymerization may further lower measured function; the study did not separate these processes.
Show evidence (1 reference)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"PF1 + 2 and PIC were markedly increased in both AFE (n = 27) and severe PA (n = 12) compared to controls (n = 23), without significant difference between those disease groups"
Reduced Functional Fibrinogen
Severely reduced Clauss fibrinogen can reflect consumption, degradation and impaired fibrin polymerization. Their separate contributions were not quantified in the selected Japanese cohort, which did not measure fibrinogen antigen or a functional-to-antigen ratio.
Downstream
Impaired Hemostasis Reduced functional fibrinogen compromises clot formation and bleeding control.
Hypofibrinogenaemia Reduced measured functional fibrinogen corresponds to this laboratory phenotype.
Show evidence (2 references)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group"
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study."
Impaired Hemostasis
Loss of functional fibrinogen, other clotting-factor deficits and platelet abnormalities impair hemostasis and can produce severe obstetric or diffuse bleeding. The degree of thrombocytopenia varies; three relatively platelet-preserved cases do not define the whole disease.
Downstream
Reduced Systemic Perfusion Severe blood loss can worsen systemic hypoperfusion.
Postpartum Haemorrhage Impaired hemostasis exacerbates bleeding after delivery.
Show evidence (1 reference)
PMID:32157417 SUPPORT PRIMARY RESULT Human Clinical
"Disproportionately low levels of fibrinogen and factor five, and exorbitantly elevated D-dimers were present in all cases, whereas markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced."
Three consecutive cases, not a universal phenotype.
Maternal Tissue Oxygen Deprivation
Reduced systemic perfusion and hypoxemia compromise tissue oxygen delivery, potentially contributing to cerebral and other organ injury. Individual seizures or focal cerebral infarctions are not fully explained by this general pathway.
Downstream
Seizures Cerebral oxygen deprivation can contribute to seizures, without explaining every episode.
Coma Severe cerebral oxygen deprivation can impair consciousness.
Acute Kidney Injury Hypoperfusion can contribute to renal injury; disease-specific intermediates are unresolved.
Show evidence (1 reference)
PMID:35840499 SUPPORT REVIEW SYNTHESIS Other
"The goals are the rapid correction of haemodynamic instability and hypoxia, preventing additional hypoxia and end-organ failure"
Fetal Oxygen Deprivation
Maternal cardiopulmonary compromise can reduce oxygen delivery to a fetus still in utero. This downstream fetal consequence is conditional on timing; neonatal outcomes also depend on gestation and other conditions.
Show evidence (2 references)
PMID:26703453 SUPPORT BACKGROUND Human Clinical
"Fetal heart rate abnormalities are a common presenting feature of AFE,"
Clinical interpretation of fetal compromise in a prospective maternal cohort.
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Other
"as oxygenated blood is shunted away from the uterus"
Guideline synthesis of fetal perfusion compromise.
✶

Histopathology

2
Fetal squamous material in maternal pulmonary vessels
Fetal squames or other amniotic components have been described in maternal pulmonary vessels at autopsy. Presence is neither required nor pathognomonic, and does not demonstrate that mechanical occlusion caused collapse.
Show evidence (1 reference)
PMID:25807263 SUPPORT REVIEW SYNTHESIS Human Clinical
"The presence of squamous cells in the maternal pulmonary artery circulation is no longer considered pathognomonic."
Pulmonary mast-cell degranulation
Extracellular tryptase staining in selected fatal AFE lung series supports local degranulation. These observations do not establish a validated diagnostic test or a causal mediator common to all cases.
Show evidence (1 reference)
PMID:25807263 SUPPORT REVIEW SYNTHESIS Human Clinical
"These studies, therefore, highlight that mast cell degranulation occurs in the lungs of AFE fatal cases, whereas it does not occur in other fatal pregnancies."
Review synthesis of selected autopsy series, not proof of specificity across all causes of death.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Amniotic Fluid Embolism Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

21
Blood 4
Disseminated Intravascular Coagulation HP:0005521 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Disseminated intravascular coagulation (HP:0005521). HP:0005521 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:26703453 SUPPORT PRIMARY RESULT Human Clinical
"| | Coagulopathy | 24 (73 %) |"
Associated feature among 33 prospectively reported cases, using a broader case definition.
PMID:27372270 SUPPORT REVIEW SYNTHESIS Other
"Documentation of overt disseminated intravascular coagulation (DIC) using the scoring system"
DIC is part of the strict research definition, rather than an independent prevalence observation.
Hypofibrinogenaemia Hypofibrinogenemia HP:0011900 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypofibrinogenemia (HP:0011900). HP:0011900 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group"
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study."
Thrombocytopenia HP:0001873 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Thrombocytopenia (HP:0001873). HP:0001873 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:26703453 SUPPORT PRIMARY RESULT Human Clinical
"| | Platelets <100 10 9 /L | 20 (61 %) |"
Worst recorded value in Table 4.
PMID:32157417 SUPPORT PRIMARY RESULT Human Clinical
"markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced"
Three cases only.
Postpartum Haemorrhage Post-partum hemorrhage HP:0011891 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Post-partum hemorrhage (HP:0011891), qualified as severity severe. HP:0011891 is a phenotype from the Human Phenotype Ontology.
Severity: SEVERE
Show evidence (1 reference)
PMID:24888909 SUPPORT REVIEW SYNTHESIS Human Clinical
"the presence of disseminated intravascular coagulation (DIC) and atonic bleeding"
Cardiovascular 4
Cardiac Arrest HP:0001695 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cardiac arrest (HP:0001695), qualified as temporality acute. HP:0001695 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (2 references)
PMID:26703453 SUPPORT PRIMARY RESULT Human Clinical
"| | Cardiac arrest | 13 (39 %) |"
Table 3, associated features among 33 reported cases.
PMID:42730345 SUPPORT REVIEW SYNTHESIS Human Clinical
"Cardiac arrest accompanies many cases of AFE, but not all"
Profound Hypotension HP:0002615 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypotension (HP:0002615), qualified as temporality acute; severity severe. HP:0002615 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE Severity: SEVERE
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"| Hypotension | 54/54 (100.0) | 8/10 (80.0) | 0.001 |"
Table 3; selected typical and atypical groups with available observations.
Cerebral Infarction in Survivors Ischemic stroke HP:0002140 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cerebral infarction, annotated with Ischemic stroke (HP:0002140). HP:0002140 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:21126320 SUPPORT PRIMARY RESULT Human Clinical
"survivors were at increased risk of cerebral infarction"
Cardiac Arrhythmia HP:0011675 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Arrhythmia (HP:0011675). HP:0011675 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:26703453 SUPPORT PRIMARY RESULT Human Clinical
"| | Abnormal cardiac rhythm | 8 (24 %) |"
Table3 associated features; no disease-wide frequency inferred.
Genitourinary 1
Acute Kidney Injury HP:0001919 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Acute kidney injury (HP:0001919). HP:0001919 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
url:https://www.ncbi.nlm.nih.gov/sites/books/NBK559107/ SUPPORT REVIEW SYNTHESIS Human Clinical
"acute renal failure due to acute tubular necrosis"
Integument 1
Cyanosis HP:0000961 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cyanosis (HP:0000961), qualified as temporality acute. HP:0000961 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:25807263 SUPPORT REVIEW SYNTHESIS Human Clinical
"with dyspnoea, cyanosis and/or respiratory arrest"
Metabolism 1
Pulmonary Oedema Pulmonary edema HP:0100598 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Pulmonary edema (HP:0100598). HP:0100598 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"| Pulmonary Edema | 9/46 (19.6) | 5/10 (50.0) | 0.04 |"
Exact table counts; the narrative comparison is inconsistent.
Nervous System 3
Seizures HP:0001250 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Seizure (HP:0001250), qualified as temporality acute. HP:0001250 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:28188959 SUPPORT REVIEW SYNTHESIS Human Clinical
"the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy (DIC)"
Coma HP:0001259 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Coma (HP:0001259), qualified as temporality acute. HP:0001259 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:25807263 SUPPORT REVIEW SYNTHESIS Human Clinical
"coagulopathies (disseminated intravascular coagulation and/or severe hemorrhage), coma and seizures"
Headache HP:0002315 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Headache (HP:0002315). HP:0002315 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"| Headache | 3/50 (6.0) | 4/13 (30.8) | 0.01 |"
Selected voluntary registry, variable available-data denominators; no population frequency inferred.
Respiratory 5
Acute Hypoxaemia Hypoxemia HP:0012418 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hypoxemia (HP:0012418), qualified as temporality acute. HP:0012418 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:28188959 SUPPORT REVIEW SYNTHESIS Human Clinical
"characterized by the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy"
Dyspnoea Dyspnea HP:0002094 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Dyspnea (HP:0002094), qualified as temporality acute. HP:0002094 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:25807263 SUPPORT REVIEW SYNTHESIS Human Clinical
"acute hypoxia (with dyspnoea, cyanosis and/or respiratory arrest)"
Respiratory Failure Requiring Ventilatory Support HP:0002878 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Respiratory failure (HP:0002878), qualified as temporality acute. HP:0002878 is a phenotype from the Human Phenotype Ontology.
Temporal: ACUTE
Show evidence (1 reference)
PMID:26703453 SUPPORT PRIMARY RESULT Human Clinical
"| Intubation/Ventilation | | 14 (42 %) |"
Table 4 reports the intervention directly.
Bronchospasm Bronchoconstriction HP:4000007 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Bronchoconstriction (HP:4000007). HP:4000007 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"| Bronchospasm | 5/34 (14.7) | 2/10 (20.0) | 0.7 |"
Selected voluntary registry, variable available-data denominators; no population frequency inferred.
Cough HP:0012735 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Cough (HP:0012735). HP:0012735 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"| Cough | 2/48 (4.1) | 2/13 (15.4) | 0.1 |"
Selected voluntary registry, variable available-data denominators; no population frequency inferred.
Constitutional 1
Chest Pain HP:0100749 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Chest pain (HP:0100749). HP:0100749 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"| Chest Pain | 6/48 (12.5) | 3/13 (23.1) | 0.3 |"
Selected voluntary registry, variable available-data denominators; no population frequency inferred.
Other 1
Uterine Atony
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"| Uterine Atony | 28/51 (54.9) | 3/11 (27.2) | 0.1 |"
Selected voluntary registry, variable available-data denominators; no population frequency inferred.
💊

Medical Actions

13
Immediate Cardiopulmonary Resuscitation
Action: resuscitationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is resuscitation (NCIT:C50822). NCIT:C50822 is a clinical intervention from the NCI Thesaurus. Ontology label: Resuscitation NCIT:C50822
Platform: Other
For cardiac arrest, begin high-quality CPR and standard advanced life support immediately while the obstetric emergency team responds; diagnosis must not delay resuscitation. Relieve aortocaval compression with manual lateral uterine displacement. The 2016 SMFM recommendation was GRADE 1C; the 2026 checklist reinforces pregnancy-specific resuscitation.
Mechanism Target:
BYPASSES Reduced Systemic Perfusion — Chest compressions provide temporary circulation during arrest.
Show evidence (2 references)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we recommend the provision of immediate high-quality cardiopulmonary resuscitation with standard basic cardiac life support and advanced cardiac life support protocols in patients who develop cardiac arrest associated with amniotic fluid embolism"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Priorities for pregnant people in cardiac arrest should include the provision of high‐quality cardiopulmonary resuscitation (CPR) and relief of aortocaval compression with lateral uterine displacement"
Show evidence (2 references)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we recommend the provision of immediate high-quality cardiopulmonary resuscitation with standard basic cardiac life support and advanced cardiac life support protocols in patients who develop cardiac arrest associated with amniotic fluid embolism"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Priorities for pregnant people in cardiac arrest should include the provision of high‐quality cardiopulmonary resuscitation (CPR) and relief of aortocaval compression with lateral uterine displacement"
Vasopressor Support
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: noradrenaline CHEBI:33569 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses noradrenaline (CHEBI:33569). CHEBI:33569 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
Use vasopressors when hypotension requires support, guided by hemodynamic status. Severe right ventricular compromise favors pressure support over indiscriminate fluid loading; bleeding still requires appropriate blood-product resuscitation.
Mechanism Target:
MODULATES Reduced Systemic Perfusion — Supports pressure and organ perfusion without correcting the initiating insult.
Show evidence (1 reference)
PMID:31376394 SUPPORT REVIEW SYNTHESIS Other
"Blood pressure support with vasopressors is preferred over fluid infusion in the setting of severe right ventricular compromise."
Show evidence (1 reference)
PMID:31376394 SUPPORT REVIEW SYNTHESIS Other
"Blood pressure support with vasopressors is preferred over fluid infusion in the setting of severe right ventricular compromise."
Inotropic Support
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: dobutamine CHEBI:4670 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses dobutamine (CHEBI:4670). CHEBI:4670 is a therapeutic agent from Chemical Entities of Biological Interest. milrinone CHEBI:50693 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses milrinone (CHEBI:50693). CHEBI:50693 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
Use echo-guided inotropic support for significant ventricular dysfunction. Dobutamine or milrinone may be selected by the critical-care team; no comparative AFE drug trial establishes a universally preferred agent.
Mechanism Target:
MODULATES Acute Right Ventricular Failure — Supports contractile performance of a failing right ventricle.
Show evidence (1 reference)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Inotropes and pulmonary vasodilators are the primary therapies; transthoracic or transesophageal echocardiography can be used to guide therapy."
MODULATES Left Ventricular Contractile Dysfunction — Supports left ventricular contractility when impaired.
Show evidence (1 reference)
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Other
"inotropes (dobutamine or milrinone) to increase left ventricular contractility."
Show evidence (2 references)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Inotropes and pulmonary vasodilators are the primary therapies; transthoracic or transesophageal echocardiography can be used to guide therapy."
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Other
"inotropes (dobutamine or milrinone) to increase left ventricular contractility."
Pulmonary Vasodilator Therapy
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: inhaled nitric oxide CHEBI:16480 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses inhaled nitric oxide, annotated with nitric oxide (CHEBI:16480). CHEBI:16480 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
Consider pulmonary vasodilators to reduce right ventricular afterload in documented pulmonary hypertension/right ventricular failure, under expert hemodynamic monitoring. Inhaled nitric oxide or prostacyclin are options; use is targeted rather than routine for every respiratory presentation.
Mechanism Target:
INHIBITS Pulmonary Vasoconstriction — Reduces pulmonary vasoconstriction and ventricular afterload.
Show evidence (1 reference)
PMID:31376394 SUPPORT REVIEW SYNTHESIS Other
"If such failure is identified, treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators."
Show evidence (1 reference)
PMID:31376394 SUPPORT REVIEW SYNTHESIS Other
"If such failure is identified, treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators."
Hemostatic Resuscitation and Fibrinogen Replacement
Action: blood transfusionNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is blood transfusion (NCIT:C15192). NCIT:C15192 is a clinical intervention from the NCI Thesaurus. Ontology label: Blood Transfusion NCIT:C15192
Platform: Other
Activate the massive transfusion protocol for severe bleeding and assess coagulation early. Replace red cells, plasma and platelets according to the evolving deficit, with prompt fibrinogen replacement using cryoprecipitate or locally appropriate concentrates. The 2026 checklist describes approximately 1:1:1 component resuscitation and favors concentrated cryoprecipitate for fibrinogen support to limit volume overload; this does not replace every plasma indication. Avoid excessive crystalloid or colloid loading.
Mechanism Target:
RESTORES Reduced Functional Fibrinogen — Replaces deficient functional fibrinogen.
Show evidence (2 references)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"in AFE, cryoprecipitate is favored over fresh or frozen plasma to limit the risk of volume overload while addressing coagulopathy"
RESTORES Impaired Hemostasis — Replaces deficient hemostatic components while bleeding sources are controlled.
Show evidence (2 references)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"in AFE, cryoprecipitate is favored over fresh or frozen plasma to limit the risk of volume overload while addressing coagulopathy"
Show evidence (2 references)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"in AFE, cryoprecipitate is favored over fresh or frozen plasma to limit the risk of volume overload while addressing coagulopathy"
Tranexamic Acid
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: tranexamic acid CHEBI:48669 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses tranexamic acid (CHEBI:48669). CHEBI:48669 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
The 2026 SMFM checklist includes tranexamic acid for AFE-associated DIC or hemorrhage. It suppresses fibrinolysis and accompanies blood-product resuscitation and source control. The observational AFE biomarker study did not test treatment efficacy; do not infer an AFE-specific survival effect from its mechanistic rationale.
Mechanism Target:
INHIBITS Excessive Plasmin Generation — Limits plasmin generation and fibrin-associated fibrinolysis.
Show evidence (2 references)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"including the use of uterotonic agents, administration of tranexamic acid"
PMID:38168649 SUPPORT BACKGROUND Other
"Tranexamic acid, a universally available antifibrinolytic agent, inhibits plasminogen from binding with fibrin and suppresses production of plasmin"
Background pharmacology in the observational study.
Show evidence (2 references)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"including the use of uterotonic agents, administration of tranexamic acid"
PMID:38168649 SUPPORT BACKGROUND Other
"Tranexamic acid, a universally available antifibrinolytic agent, inhibits plasminogen from binding with fibrin and suppresses production of plasmin"
Background pharmacology in the observational study.
Resuscitative Delivery During Maternal Cardiac Arrest
Action: cesarean sectionNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cesarean section (NCIT:C46088). NCIT:C46088 is a clinical intervention from the NCI Thesaurus. Ontology label: Cesarean Section NCIT:C46088
Platform: Surgery
Prepare for immediate delivery during maternal arrest; the 2026 checklist calls for cesarean delivery to be started within 4 minutes when circulation has not returned. Uterine evacuation can improve maternal hemodynamics as well as fetal outcome. Perform it where the patient is located if transfer would delay treatment. Operative vaginal delivery is an option only when complete dilation and a crowning head allow prompt birth. Apply the pregnancy cardiac-arrest protocol and individual clinical circumstances; the older 2016 guideline used a fetal viability threshold of 23 weeks.
Mechanism Target:
MODULATES Reduced Systemic Perfusion — Relieves gravid uterine compression during maternal resuscitation.
Show evidence (2 references)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Immediate delivery can improve maternal hemodynamics and, in a patient receiving CPR, should be initiated within 4 min to increase the likelihood of return of spontaneous circulation"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Operative vaginal delivery can be considered if the cervix is completely dilated and the fetal head is crowning"
BYPASSES Fetal Oxygen Deprivation — Delivery permits direct neonatal support when fetal oxygen delivery is compromised.
Show evidence (2 references)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Immediate delivery can improve maternal hemodynamics and, in a patient receiving CPR, should be initiated within 4 min to increase the likelihood of return of spontaneous circulation"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Operative vaginal delivery can be considered if the cervix is completely dilated and the fetal head is crowning"
Show evidence (2 references)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Immediate delivery can improve maternal hemodynamics and, in a patient receiving CPR, should be initiated within 4 min to increase the likelihood of return of spontaneous circulation"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"Operative vaginal delivery can be considered if the cervix is completely dilated and the fetal head is crowning"
Venoarterial Extracorporeal Membrane Oxygenation
Action: extracorporeal membrane oxygenationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is extracorporeal membrane oxygenation (NCIT:C171507). NCIT:C171507 is a clinical intervention from the NCI Thesaurus. Ontology label: Extracorporeal Membrane Oxygenation NCIT:C171507
Platform: Device
Consider VA-ECMO for prolonged arrest or severe ventricular failure refractory to medical management at an experienced center. Coagulopathy does not automatically exclude support, but cannulation and anticoagulation require individualized bleeding-risk management. Published cases are selected and cannot establish comparative survival benefit.
Mechanism Target:
BYPASSES Reduced Systemic Perfusion — Provides temporary extracorporeal circulatory support.
Show evidence (2 references)
PMID:31376394 SUPPORT REVIEW SYNTHESIS Other
"In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given."
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"For hemodynamically refractory cases, extracorporeal membrane oxygenation can be considered, even in the context of coagulopathy"
BYPASSES Impaired Pulmonary Gas Exchange — Provides extracorporeal gas exchange.
Show evidence (2 references)
PMID:31376394 SUPPORT REVIEW SYNTHESIS Other
"In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given."
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"For hemodynamically refractory cases, extracorporeal membrane oxygenation can be considered, even in the context of coagulopathy"
Show evidence (2 references)
PMID:31376394 SUPPORT REVIEW SYNTHESIS Other
"In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given."
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"For hemodynamically refractory cases, extracorporeal membrane oxygenation can be considered, even in the context of coagulopathy"
Oxygenation and Ventilatory Support
Action: mechanical ventilationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is mechanical ventilation (NCIT:C70909). NCIT:C70909 is a clinical intervention from the NCI Thesaurus. Ontology label: Mechanical Ventilation NCIT:C70909
Platform: Device
Provide oxygen and assisted ventilation as required by respiratory status, including airway protection and mechanical ventilation when needed. Avoid hypoxemia and excessive ventilation; after arrest, titrate oxygen rather than maintaining unnecessary hyperoxia.
Mechanism Target:
BYPASSES Impaired Pulmonary Gas Exchange — Supports oxygenation while the pulmonary and cardiovascular insult is treated.
Show evidence (2 references)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we recommend the provision of adequate oxygenation and ventilation"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"starting 100% oxygen, obtaining intravenous access, and providing ventilation with bag‐mask support or endotracheal intubation"
Show evidence (3 references)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we recommend the provision of adequate oxygenation and ventilation"
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"starting 100% oxygen, obtaining intravenous access, and providing ventilation with bag‐mask support or endotracheal intubation"
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Other
"The inspired fraction of oxygen should be weaned to maintain a pulse oxymetry value of 94-98%."
Control of Uterine Atony and Other Bleeding Sources
Platform: Other
Use uterotonics, examine for genital tract trauma and address obstetric sources of hemorrhage while correcting coagulopathy. Refractory atony may require balloon tamponade, compression sutures, arterial control or hysterectomy. These are severity-dependent escalation options, not universal treatment requirements.
Mechanism Target:
MODULATES Uterine Atony — Uterotonics and mechanical or surgical control improve uterine bleeding control.
Show evidence (2 references)
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Human Clinical
"Uterine atony is common with amniotic fluid embolism and should be managed aggressively."
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Other
"Extreme cases may need bilateral uterine artery ligation, B-Lynch stitch, or hysterectomy."
INHIBITS Postpartum Haemorrhage — Treats concurrent obstetric bleeding sources.
Show evidence (2 references)
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Human Clinical
"Uterine atony is common with amniotic fluid embolism and should be managed aggressively."
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Other
"Extreme cases may need bilateral uterine artery ligation, B-Lynch stitch, or hysterectomy."
Show evidence (2 references)
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Human Clinical
"Uterine atony is common with amniotic fluid embolism and should be managed aggressively."
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Other
"Extreme cases may need bilateral uterine artery ligation, B-Lynch stitch, or hysterectomy."
Psychological Support and Post-Event Follow-Up
Platform: Other
Assess physical recovery, neurologic deficits and mental health after severe maternal illness. Offer trauma-informed support and referral for persistent post-traumatic stress or depression symptoms. Discuss subsequent pregnancies individually because reassuring small series do not establish zero recurrence risk.
Show evidence (2 references)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"the need for psychological and emotional support for the patient, family members, and clinical staff should be recognized."
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"All of the patients who reported post-traumatic stress symptoms were surveyed about their mental health resources and were referred to local facilities for mental health care."
Avoid Routine Atropine-Ondansetron-Ketorolac Regimen
Platform: Other
The corrected 2026 SMFM statement reports an expert recommendation against routine AOK treatment: evidence is limited to case reports and potential harms include renal dysfunction, bleeding, arrhythmia and myocardial injury. Atropine is not a routine AFE treatment in the absence of bradycardia.
Show evidence (1 reference)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"recommends against the routine use of the atropine, ondansetron, and ketorolac regimen."
C1 Esterase Inhibitor Replacement (Investigational)
Platform: Other
Reduced endogenous activity supplies a research rationale, but no cited controlled study establishes that replacement improves AFE outcomes. It is not standard resuscitative therapy and should not be represented as proven reversal of an established causal deficiency.
Show evidence (1 reference)
PMID:24888909 SUPPORT REVIEW SYNTHESIS Other
"C1 esterase inhibitor may be a promising candidate of treatment of AFE."
Author-proposed therapy, not an efficacy finding.
🔬

Biochemical Markers

6
C1 esterase inhibitor activity (Decreased)
Show evidence (1 reference)
PMID:24561565 SUPPORT PRIMARY RESULT Human Clinical
"C1 esterase inhibitor activity levels were significantly lower in amniotic fluid embolism patients (30.0% ± 1.8%) than in control women (62.0% ± 2.0%) (p < 0.0001)."
Plasma tissue plasminogen activator antigen (Increased in the selected AFE-with-DIC cohort)
Show evidence (2 references)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"AFE had significantly increased tPA and decreased total TAFI levels compared with severe PA and controls"
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"We evaluated antigen levels, not activity, for the plasma tPA and total TAFI"
Total thrombin-activatable fibrinolysis inhibitor antigen (Decreased in the selected AFE-with-DIC cohort)
Show evidence (2 references)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"Since the capture antibody in the ELISA kit used in the present study detects both TAFI and TAFIa antigens according to the manufacturer, we described the amount of TAFI and TAFIa measured together with the kit as total TAFI."
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"AFE had significantly increased tPA and decreased total TAFI levels compared with severe PA and controls"
Prothrombin fragment 1+2 and plasmin–antiplasmin complex (Increased in selected coagulopathic cases)
Show evidence (1 reference)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"PF1 + 2 and PIC were markedly increased in both AFE (n = 27) and severe PA (n = 12) compared to controls (n = 23), without significant difference between those disease groups"
D-dimer and functional fibrinogen (Elevated D-dimer with reduced Clauss fibrinogen)
Show evidence (2 references)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group"
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study."
Circulating inflammatory cytokines (Markedly increased in an individual fatal case)
Show evidence (2 references)
PMID:41765067 SUPPORT PRIMARY RESULT Human Clinical
"The present analysis involved two plasma specimens from this patient: (1) an admission sample obtained before the onset of symptoms/diagnosis and (2) a sample collected at the time of AFE diagnosis."
PMID:41765067 SUPPORT PRIMARY RESULT Human Clinical
"The admission plasma sample, obtained when the patient appeared completely asymptomatic, showed extraordinary elevations of key inflammatory cytokines relative to women in labor."
Single-case observation against six term-labor and six term-not-in-labor controls.
🔬

Diagnosis

4
Clinical Diagnosis and Immediate Differential Assessment
AFE is a clinical diagnosis in sudden peripartum cardiopulmonary compromise with coagulopathy after considering alternative causes. Resuscitation proceeds while the differential is evaluated. No individual laboratory assay, fetal squame finding or cytokine result can currently confirm or exclude AFE.
Show evidence (1 reference)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we do not recommend the use of any specific diagnostic laboratory test to either confirm or refute the diagnosis of amniotic fluid embolism; at the present time, amniotic fluid embolism remains a clinical diagnosis"
Strict Criteria for Research Reporting
The 2016 research definition requires sudden arrest, or hypotension with respiratory compromise; overt DIC before blood loss sufficient to explain the coagulopathy; onset during labor or within 30 minutes of placental delivery; and no intrapartum fever of 38°C or higher. These criteria deliberately exclude some atypical clinical cases and should not be used to delay support or automatically rule out clinical AFE. In 115 selected registry charts, 54 fulfilled the criteria and 14 additional cases were considered AFE by expert review; the comparator was expert consensus, not a diagnostic gold standard.
Show evidence (2 references)
PMID:27372270 SUPPORT REVIEW SYNTHESIS Other
"This approach is intended to apply only to patients included in research reports"
PMID:30481492 SUPPORT PRIMARY RESULT Human Clinical
"The 14 cases (21%) identified by the expert panel as AFE that did not meet the objective criteria are believed to represent atypical presentations of this condition."
Echocardiography to Characterize Hemodynamic Failure
Bedside transthoracic or transesophageal echocardiography assesses right and left ventricular function, septal displacement and pulmonary hypertension to guide therapy and evaluate alternative cardiac causes. The pattern is not independently diagnostic of AFE.
Echocardiography Test NCIT:C16525 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:31376394 SUPPORT REVIEW SYNTHESIS Other
"we recommend performing transthoracic or transesophageal echocardiography as soon as possible because this is an easy and reliable method of identifying a failing right ventricle."
Serial Coagulation and Organ-Function Assessment
Assess blood count, platelets, fibrinogen, coagulation times, blood gases and organ function early and repeatedly as clinically indicated. Viscoelastic assays can assist rapid hemostatic management where available. These measurements guide support, rather than specifically identifying AFE.
Show evidence (1 reference)
PMID:26987420 SUPPORT REVIEW SYNTHESIS Other
"we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols"
📈

Progression

2
Acute peripartum presentation
Presentation is usually abrupt during labor or shortly after delivery, but broader surveillance definitions include later and atypical presentations. Cardiopulmonary compromise and coagulopathy may overlap; an obligatory sequential four-stage course is not established.
Show evidence (2 references)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Human Clinical
"Cardiac arrest accompanies many cases of AFE, but not all"
PMID:26703453 SUPPORT PRIMARY RESULT Human Clinical
"Five women presented 30 min or more after delivery."
Recovery and sequelae
Survivors may require prolonged critical care and follow-up for neurologic, other organ and psychological sequelae. Available studies often ascertain only early outcomes; selected survivors with later pregnancies do not define recurrence risk.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"Among women who survived either atypical or typical AFE, long-term complications that include medical and psychological manifestations involving depression and post-traumatic stress disorder (PTSD) symptoms, were recorded from those contacted and available for interview at least 1 year post-event."
📊

Prevalence

4
Australia and New Zealand
Birth Prevalence 5.4 per 100,000 (3.5–7.2) 1–9 per 100,000 (births)
Prospective AMOSS surveillance in 2010–2011 recorded 33 cases among an estimated 613,731 women giving birth. Site participation increased during rollout, and denominators were adjusted for active days. Case criteria included clinical cardiopulmonary/coagulation findings or postmortem findings. The denominator is women giving birth, not person-time; BIRTH_PREVALENCE is used for the available birth-based measure, not congenital prevalence.
Show evidence (1 reference)
PMID:26703453 SUPPORT PRIMARY RESULT Human Clinical
"with an estimated incidence of 5.4 cases per 100,000 women giving birth (95% CI 3.5 to 7.2 per 100,000)"
United States
Birth Prevalence 4.9 per 100,000 1–9 per 100,000 (births)
Weighted US Nationwide Inpatient Sample estimates for 2000–2019; administrative ascertainment and changing diagnostic practice limit comparison with adjudicated registries. The abstract contains an internally inconsistent mortality confidence interval, which is not reproduced.
Show evidence (1 reference)
PMID:38219609 SUPPORT PRIMARY RESULT Human Clinical
"Over the study period, AFE incidence rate remained stable (mean 4.9 cases/100,000 deliveries) and the case-fatality rate declined"
Australia (linked population data)
Birth Prevalence 3.3 per 100,000 (1.9–4.7) 1–9 per 100,000 (births)
Whole-population linked birth, hospital and death data with additional case-definition criteria imposed.
Show evidence (1 reference)
PMID:21126320 SUPPORT PRIMARY RESULT Human Clinical
"The AFE incidence was 3.3 per 100,000 (95% CI, 1.9-4.7), maternal fatality rate 35% (95% CI, 15-59) and perinatal mortality rate 32% (95% CI, 12-56)."
Canada (singleton deliveries)
Birth Prevalence 6.0 per 100,000 1–9 per 100,000 (births)
From a three-million-delivery cohort. The same study reports 14.8 per 100,000 for multiple-birth deliveries, so the denominator matters.
Show evidence (1 reference)
PMID:17055946 SUPPORT PRIMARY RESULT Human Clinical
"Total rate of amniotic-fluid embolism was 14.8 per 100,000 multiple-birth deliveries and 6.0 per 100,000 singleton deliveries"
⚖️

Clinical Burden

High
Although rare, AFE can cause maternal death, emergency hysterectomy, critical illness, neurologic injury and substantial psychological morbidity. Population estimates and survival differ with ascertainment and diagnostic criteria. There is no validated screening test or established prevention strategy; treatment requires a coordinated emergency response.
Show evidence (2 references)
PMID:26703453 SUPPORT PRIMARY RESULT Human Clinical
"Five woman died (case fatality rate 15%)"
Five deaths among 33 prospectively reported cases; not a universal mortality rate.
PMID:42730345 SUPPORT REVIEW SYNTHESIS Other
"the need for psychological and emotional support for the patient, family members, and clinical staff should be recognized."
🔀

Differential Diagnoses

6

Conditions with similar clinical presentations that must be differentiated from Amniotic Fluid Embolism:

Postpartum hemorrhage with hypovolemic shock
Distinguishing Features
  • Primary obstetric blood loss can produce shock and secondary dilutional or consumptive coagulopathy. Establish the sequence of bleeding, coagulopathy and cardiorespiratory collapse; hemorrhage alone does not establish AFE.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"the most common actual diagnosis was hypovolemic shock secondary to postpartum hemorrhage (n=21, 77.7%)"
Among 27 alternative diagnoses in a selected registry.
Anesthetic complications
Distinguishing Features
  • High neuraxial block or local-anesthetic systemic toxicity can cause abrupt respiratory or cardiovascular compromise. Timing relative to anesthetic administration and neurologic findings help distinguish these conditions; coagulopathy is not their usual initial feature.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"followed by anesthetic complications (n = 4, 14.8%)"
Sepsis
Distinguishing Features
  • Infection can cause respiratory failure, cardiovascular collapse and DIC. Fever, infection evidence and time course inform the differential, but their absence does not by itself prove AFE.
Show evidence (1 reference)
PMID:33345954 SUPPORT PRIMARY RESULT Human Clinical
"sepsis-related cardiovascular collapse (n = 2, 7.4%)."
Placental abruption with disseminated intravascular coagulation
Distinguishing Features
  • Abruption can cause bleeding, fetal compromise and severe coagulopathy. PF1+2 and PIC elevations overlap with selected AFE cases; differences in correlations or tPA/TAFI antigen concentrations are not validated bedside discriminators.
Show evidence (1 reference)
PMID:38168649 SUPPORT PRIMARY RESULT Human Clinical
"Both AFE and sPA were associated with activation of coagulation and massive fibrinolysis without significant difference in each plasma maker between the groups."
Pulmonary thromboembolism, myocardial infarction and air embolism
Distinguishing Features
  • These are alternative causes of abrupt peripartum collapse requiring directed evaluation and treatment. Echocardiography, ECG and appropriate vascular imaging are selected according to clinical stability; right ventricular dysfunction alone does not prove AFE.
Show evidence (1 reference)
PMID:42730345 SUPPORT REVIEW SYNTHESIS Human Clinical
"The differential diagnosis of AFE includes pulmonary embolism, myocardial infarction, air embolism, high spinal block, and sepsis."
Anaphylaxis, eclampsia and peripartum cardiomyopathy
Distinguishing Features
  • Drug exposure with rash or bronchospasm, hypertensive disease with seizures, or predominant left ventricular failure may favor these alternatives. No single clinical sign safely excludes competing causes of collapse.
Show evidence (2 references)
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Human Clinical
"includes myocardial infarction, pulmonary embolism, air embolism, anesthetic complications, anaphylaxis, and eclampsia and in some cases sepsis."
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf SUPPORT REVIEW SYNTHESIS Human Clinical
"Echocardiography will also aid in ruling out conditions such as a peripartum dilated cardiomyopathy."
{ }

Source YAML

click to show 
name: Amniotic Fluid Embolism
creation_date: '2026-08-17T09:00:00Z'
category: Complex
synonyms:
- AFE
- Anaphylactoid syndrome of pregnancy
description: Amniotic fluid embolism is a rare peripartum syndrome of sudden respiratory compromise, cardiovascular collapse and coagulopathy. Presentation and timing vary with the case definition; cardiac arrest occurs in many, but not all, cases. Abnormal maternal inflammatory responses to material from the fetal compartment are proposed, but the initiating exposure, susceptibility factors and causal mediator sequence remain unresolved. Pulmonary hypertension and acute right ventricular dysfunction can reduce systemic blood flow; left ventricular dysfunction and pulmonary edema may follow. Coagulation activation and excessive fibrinolysis contribute to severe bleeding, without establishing that thrombosis is absent. Diagnosis remains clinical, with urgent exclusion of alternative causes of maternal collapse. Treatment centers on resuscitation, hemodynamic and respiratory support, correction of bleeding and coagulopathy, and resuscitative delivery when indicated.
disease_term:
  preferred_term: amniotic fluid embolism
  term:
    id: MONDO:0850046
    label: amniotic fluid embolism
parents:
- Pregnancy disorder
- Obstetric emergency
- Peripartum cardiovascular collapse
clinical_burden:
  burden_level: HIGH
  rationale: Although rare, AFE can cause maternal death, emergency hysterectomy, critical illness, neurologic injury and substantial psychological morbidity. Population estimates and survival differ with ascertainment and diagnostic criteria. There is no validated screening test or established prevention strategy; treatment requires a coordinated emergency response.
  evidence:
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Five woman died (case fatality rate 15%)
    explanation: Five deaths among 33 prospectively reported cases; not a universal mortality rate.
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: the need for psychological and emotional support for the patient, family members, and clinical staff should be recognized.
prevalence:
- population: Australia and New Zealand
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 5.4
  rate_low: 3.5
  rate_high: 7.2
  notes: Prospective AMOSS surveillance in 2010–2011 recorded 33 cases among an estimated 613,731 women giving birth. Site participation increased during rollout, and denominators were adjusted for active days. Case criteria included clinical cardiopulmonary/coagulation findings or postmortem findings. The denominator is women giving birth, not person-time; BIRTH_PREVALENCE is used for the available birth-based measure, not congenital prevalence.
  evidence:
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: with an estimated incidence of 5.4 cases per 100,000 women giving birth (95% CI 3.5 to 7.2 per 100,000)
    quote_role: PRIMARY_RESULT
- population: United States
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 4.9
  notes: Weighted US Nationwide Inpatient Sample estimates for 2000–2019; administrative ascertainment and changing diagnostic practice limit comparison with adjudicated registries. The abstract contains an internally inconsistent mortality confidence interval, which is not reproduced.
  evidence:
  - reference: PMID:38219609
    reference_title: 'Amniotic fluid embolism: 20-year incidence and case-fatality trends in the United States.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Over the study period, AFE incidence rate remained stable (mean 4.9 cases/100,000 deliveries) and the case-fatality rate declined
    quote_role: PRIMARY_RESULT
- population: Australia (linked population data)
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 3.3
  rate_low: 1.9
  rate_high: 4.7
  notes: Whole-population linked birth, hospital and death data with additional case-definition criteria imposed.
  evidence:
  - reference: PMID:21126320
    reference_title: Amniotic fluid embolism in an Australian population-based cohort.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: The AFE incidence was 3.3 per 100,000 (95% CI, 1.9-4.7), maternal fatality rate 35% (95% CI, 15-59) and perinatal mortality rate 32% (95% CI, 12-56).
    quote_role: PRIMARY_RESULT
- population: Canada (singleton deliveries)
  measure_type: BIRTH_PREVALENCE
  prevalence_class: BAND_1_9_PER_100000
  rate_per_100000: 6.0
  notes: "From a three-million-delivery cohort. The same study reports 14.8 per 100,000 for multiple-birth deliveries, so the denominator matters.\n"
  evidence:
  - reference: PMID:17055946
    reference_title: 'Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: Total rate of amniotic-fluid embolism was 14.8 per 100,000 multiple-birth deliveries and 6.0 per 100,000 singleton deliveries
    quote_role: PRIMARY_RESULT
mechanistic_hypotheses:
- hypothesis_group_id: maternal_inflammatory_response
  hypothesis_label: Abnormal maternal inflammatory response to fetal-compartment exposure
  status: CANONICAL
  description: A prevailing explanatory model links fetal-compartment material entering maternal blood to inflammatory mediator activation. Neither a specific antigen nor an IgE-independent pathway has been established for every clinical presentation. Complement, mast-cell and cytokine observations are heterogeneous and do not prove an obligatory sequence.
  evidence:
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition.
  - reference: PMID:24865116
    reference_title: Incidence, diagnosis and pathophysiology of amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: To date, immunological mechanisms, amniotic fluid-dependent anaphylactic reaction and complement activation, have been proposed as potential pathogenetic and pathophysiological mechanisms.
pathophysiology:
- name: Maternal-Fetal Barrier Disruption
  biological_scale: TISSUE
  description: Disruption at the placental interface, cervical veins or uterine injury may permit transfer of fetal-compartment material. These routes are proposed triggers; a specific breach is not demonstrated in every affected patient.
  evidence:
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition.
  downstream:
  - target: Fetal Material Entry into Maternal Circulation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Disruption may permit transfer; the initiating route is inferred.
    evidence:
    - reference: PMID:24402585
      reference_title: Amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition.
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
- name: Fetal Material Entry into Maternal Circulation
  biological_scale: ORGANISM
  description: Entry of fetal-compartment material is a proposed initiating exposure. Detection of squamous cells alone neither establishes AFE nor proves obstructive embolization; such cells can occur without the syndrome.
  evidence:
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition.
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: Continued erroneous reliance on the detection of squamous cells in the pulmonary circulation as a pathognomonic criterion for AFE diagnosis regardless of clinical presentation also plays a role in erroneous diagnoses.
  downstream:
  - target: Maternal Inflammatory Mediator Activation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The inflammatory response to fetal material is proposed, without a proven specific antigen or universal pathway.
    evidence:
    - reference: PMID:24402585
      reference_title: Amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: The pathophysiology appears to involve an abnormal maternal response to fetal tissue exposure associated with breaches of the maternal-fetal physiologic barrier during parturition.
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
  - target: Coagulation Cascade Activation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Amniotic components and inflammatory activation can initiate coagulation in the proposed model; clinical antigen assays do not identify the initiating activity.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: intravascular coagulation is activated by amniotic fluid contents and SIRS
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
  - target: Complement Activation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Complement activation is proposed following exposure, but its initiating pathway is unresolved.
    evidence:
    - reference: PMID:24865116
      reference_title: Incidence, diagnosis and pathophysiology of amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: To date, immunological mechanisms, amniotic fluid-dependent anaphylactic reaction and complement activation, have been proposed as potential pathogenetic and pathophysiological mechanisms.
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
- name: Maternal Inflammatory Mediator Activation
  biological_scale: ORGANISM
  description: An abnormal inflammatory response is a leading model. A 2026 reanalysis found markedly elevated IL-6, IL-8 and IL-10 in two banked samples from one fatal clinically diagnosed case, including admission before overt collapse. Fever developed after epidural analgesia, no autopsy was performed, and microbial versus sterile triggers were unresolved. The observation does not establish a universal fetal-antigen trigger, a prediction test, or efficacy of immunomodulation.
  evidence:
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: This response and its subsequent injury appear to involve activation of proinflammatory mediators similar to that seen with the classic systemic inflammatory response syndrome.
  - reference: PMID:41765067
    reference_title: 'A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: The admission plasma sample, obtained when the patient appeared completely asymptomatic, showed extraordinary elevations of key inflammatory cytokines relative to women in labor.
    explanation: Single-case observation against six term-labor and six term-not-in-labor controls.
  downstream:
  - target: Pulmonary Vasoconstriction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Inflammatory mediators are proposed to provoke vasospasm; disease-specific mediators remain unresolved.
    evidence:
    - reference: PMID:24888909
      reference_title: 'Amniotic fluid embolism: pathophysiology and new strategies for management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: the liquids cause an anaphylactoid reaction that leads to pulmonary vasospasm and activation of platelets, white blood cells and/or complements.
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
  - target: Impaired Pulmonary Gas Exchange
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Inflammation-associated lung injury is a proposed additional respiratory route, not a fully resolved cellular mechanism.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: the majority of the survivors of the initial insult developed non-cardiogenic pulmonary oedema
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
- name: Complement Activation
  biological_scale: MOLECULAR
  description: Reduced C3 and C4 concentrations in small clinical series are compatible with complement activation, but concentrations alone do not identify the pathway, prove consumption or establish its causal role. Normal labor also changes complement measurements.
  evidence:
  - reference: PMID:24865116
    reference_title: Incidence, diagnosis and pathophysiology of amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: To date, immunological mechanisms, amniotic fluid-dependent anaphylactic reaction and complement activation, have been proposed as potential pathogenetic and pathophysiological mechanisms.
  biological_processes:
  - preferred_term: complement activation
    term:
      id: GO:0006956
      label: complement activation
    modifier: INCREASED
  downstream:
  - target: Maternal Inflammatory Mediator Activation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Complement may amplify inflammation; low concentrations alone do not establish this bridge.
    evidence:
    - reference: PMID:24865116
      reference_title: Incidence, diagnosis and pathophysiology of amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: To date, immunological mechanisms, amniotic fluid-dependent anaphylactic reaction and complement activation, have been proposed as potential pathogenetic and pathophysiological mechanisms.
      directness: INDIRECT
    - reference: PMID:24865116
      reference_title: Incidence, diagnosis and pathophysiology of amniotic fluid embolism.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Immune cell activation induced through complement activation may be associated with the mechanism that immediately initiates maternal death, only in susceptible individuals.
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
  - target: Pulmonary Mast Cell Degranulation
    causal_link_type: UNKNOWN
    description: Complement-induced degranulation is an unresolved proposed route; neither direction nor necessity is established.
    evidence:
    - reference: PMID:25807263
      reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: other aspects concerning pulmonary mast cell involvement need to be clarified, e.g., if it is a primary mechanism of AFE or a secondary process and if mast cell degranulation can happen as a result of complement activation.
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
- name: Reduced C1 Esterase Inhibitor Activity
  biological_scale: MOLECULAR
  description: A retrospective Japanese registry study measured lower activity in 106 AFE cases than in 88 uncomplicated deliveries and lower values in 21 fatal than 85 nonfatal cases. This is an association, not proof that reduced activity precedes collapse or results from consumption; prognostic utility and replacement efficacy remain unvalidated.
  evidence:
  - reference: PMID:24561565
    reference_title: C1 esterase inhibitor activity in amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: C1 esterase inhibitor activity levels were significantly lower in amniotic fluid embolism patients (30.0% ± 1.8%) than in control women (62.0% ± 2.0%) (p < 0.0001).
  downstream:
  - target: Complement Activation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Reduced inhibitory activity might permit greater complement activation; causal direction is unproven.
    evidence:
    - reference: PMID:41765067
      reference_title: 'A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: BACKGROUND
      snippet: Reduced C1 esterase inhibitor (C1-INH) activity, reported in some patients with amniotic fluid embolism, may contribute to the hyperinflammatory state by permitting unchecked activation of the complement and contact systems, and kallikrein–kinin systems
      explanation: Author-proposed pathway, not a measurement or intervention in this case.
      directness: INDIRECT
    - reference: PMID:41765067
      reference_title: 'A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: BACKGROUND
      snippet: It is not known whether C1-INH dysregulation precedes clinical deterioration or reflects downstream consumption
      explanation: The report explicitly identifies unresolved direction.
      directness: INDIRECT
    hypothesis_groups:
    - maternal_inflammatory_response
- name: Pulmonary Mast Cell Degranulation
  biological_scale: CELLULAR
  description: Extracellular tryptase and mast-cell observations in selected fatal cases support local pulmonary degranulation. Negative or inconsistent serum tryptase and urinary histamine results in other samples constrain a systemic biomarker claim, but do not refute tissue degranulation. Necessity and causal contribution remain unresolved.
  evidence:
  - reference: PMID:25807263
    reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: These studies, therefore, highlight that mast cell degranulation occurs in the lungs of AFE fatal cases, whereas it does not occur in other fatal pregnancies.
    explanation: Review synthesis of selected autopsy series, not proof of specificity across all causes of death.
  cell_types:
  - preferred_term: mast cell
    term:
      id: CL:0000097
      label: mast cell
  biological_processes:
  - preferred_term: mast cell degranulation
    term:
      id: GO:0043303
      label: mast cell degranulation
    modifier: INCREASED
- name: Pulmonary Vasoconstriction
  biological_scale: TISSUE
  description: Pulmonary vasoconstriction is proposed to raise vascular resistance during acute cardiopulmonary AFE. The responsible mediators and their contributions vary and have not been resolved by the clinical observations.
  evidence:
  - reference: PMID:24888909
    reference_title: 'Amniotic fluid embolism: pathophysiology and new strategies for management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: the liquids cause an anaphylactoid reaction that leads to pulmonary vasospasm and activation of platelets, white blood cells and/or complements.
  downstream:
  - target: Acute Pulmonary Hypertension
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Vasoconstriction increases pulmonary vascular resistance and can elevate pressure.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: causing increasing pulmonary vasoconstriction, pulmonary hypertension, acute right ventricular (RV) failure
      directness: INDIRECT
- name: Acute Pulmonary Hypertension
  biological_scale: TISSUE
  description: A rise in pulmonary vascular pressure increases right ventricular afterload. This is a clinically recognized hemodynamic pattern, rather than an obligatory finding in every AFE definition.
  evidence:
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: causing increasing pulmonary vasoconstriction, pulmonary hypertension, acute right ventricular (RV) failure
  downstream:
  - target: Acute Right Ventricular Failure
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Increased pulmonary afterload can precipitate right ventricular failure.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: causing increasing pulmonary vasoconstriction, pulmonary hypertension, acute right ventricular (RV) failure
      directness: INDIRECT
- name: Acute Right Ventricular Failure
  biological_scale: TISSUE
  description: Acute right ventricular dilation and systolic impairment may occur during the initial collapse. Echocardiography guides recognition and support; this does not establish a universal fixed sequence in all patients.
  evidence:
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: the pulmonary hypertension and right ventricular dysfunction that commonly characterize AFE
  downstream:
  - target: Impaired Left Ventricular Filling
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Right ventricular dilation can displace the septum and reduce left-sided filling.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: interventricular septum displacement to the left thus decreasing left-sided cardiac output.
      directness: INDIRECT
- name: Impaired Left Ventricular Filling
  biological_scale: TISSUE
  description: Right ventricular dilation and leftward septal displacement can impair left ventricular filling and systemic output. This mechanical consequence is distinct from intrinsic left ventricular contractile dysfunction.
  evidence:
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: interventricular septum displacement to the left thus decreasing left-sided cardiac output.
  downstream:
  - target: Reduced Systemic Perfusion
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Reduced left-sided filling diminishes systemic output.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: interventricular septum displacement to the left thus decreasing left-sided cardiac output.
      directness: INDIRECT
- name: Left Ventricular Contractile Dysfunction
  biological_scale: TISSUE
  description: Left ventricular systolic dysfunction can develop after the initial insult. Myocardial hypoxia and circulating depressant effects have been proposed, but the relative contribution and temporal sequence are not resolved for each patient.
  evidence:
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The third stage then follows with LV failure secondary to impaired LV filling, ischaemic injury to the myocardium, myocardial depressant effect (from amniotic fluid), and hypoxaemia from severe ventilation-perfusion mismatching in the lungs
    explanation: The source presents a proposed staged model, not serial proof of an obligatory sequence.
  downstream:
  - target: Reduced Systemic Perfusion
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Contractile dysfunction lowers systemic output.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: further haemodynamic instability, metabolic acidosis, and eventual multiorgan dysfunction and failure.
      directness: INDIRECT
  - target: Pulmonary Edema Formation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Left ventricular failure can produce hydrostatic pulmonary edema.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: aggravating LV failure and causing cardiogenic pulmonary oedema and further increasing the severity of hypoxaemia.
      directness: INDIRECT
- name: Reduced Systemic Perfusion
  biological_scale: ORGANISM
  description: Reduced cardiac output and, in bleeding cases, loss of circulating volume compromise maternal organ perfusion. Shock and cardiac arrest can result; the clinical presentation need not pass through every proposed cardiac phase.
  evidence:
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: further haemodynamic instability, metabolic acidosis, and eventual multiorgan dysfunction and failure.
  downstream:
  - target: Maternal Tissue Oxygen Deprivation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Reduced blood flow compromises tissue oxygen delivery.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: The goals are the rapid correction of haemodynamic instability and hypoxia, preventing additional hypoxia and end-organ failure
      directness: INDIRECT
  - target: Fetal Oxygen Deprivation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Maternal circulatory failure can compromise a fetus still in utero.
    evidence:
    - reference: PMID:26703453
      reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: BACKGROUND
      snippet: Fetal heart rate abnormalities are a common presenting feature of AFE,
      explanation: Clinical interpretation of fetal compromise in a prospective maternal cohort.
      directness: INDIRECT
    - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: as oxygenated blood is shunted away from the uterus
      explanation: Guideline synthesis of fetal perfusion compromise.
      directness: INDIRECT
  - target: Profound Hypotension
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Reduced systemic output can manifest as hypotension.
    evidence:
    - reference: PMID:33345954
      reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: '| Hypotension | 54/54 (100.0) | 8/10 (80.0) | 0.001 |'
      explanation: Table 3; selected typical and atypical groups with available observations.
      directness: INDIRECT
  - target: Cardiac Arrest
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Severe hemodynamic failure can culminate in arrest.
    evidence:
    - reference: PMID:26703453
      reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: '| | Cardiac arrest | 13 (39 %) |'
      explanation: Table 3, associated features among 33 reported cases.
      directness: INDIRECT
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Cardiac arrest accompanies many cases of AFE, but not all
      directness: INDIRECT
- name: Pulmonary Edema Formation
  biological_scale: TISSUE
  description: Pulmonary edema may have hydrostatic and permeability-related contributions during AFE and subsequent critical illness. Left ventricular failure, inflammatory lung injury and resuscitation-related fluid overload should not be treated as interchangeable or universally present.
  evidence:
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: aggravating LV failure and causing cardiogenic pulmonary oedema and further increasing the severity of hypoxaemia.
  downstream:
  - target: Impaired Pulmonary Gas Exchange
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Edema impairs pulmonary oxygen transfer.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: aggravating LV failure and causing cardiogenic pulmonary oedema and further increasing the severity of hypoxaemia.
      directness: INDIRECT
  - target: Pulmonary Oedema
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: The mechanism corresponds to the clinical edema finding.
    evidence:
    - reference: PMID:33345954
      reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: '| Pulmonary Edema | 9/46 (19.6) | 5/10 (50.0) | 0.04 |'
      explanation: Exact table counts; the narrative comparison is inconsistent.
      directness: INDIRECT
- name: Impaired Pulmonary Gas Exchange
  biological_scale: TISSUE
  description: Severe ventilation-perfusion mismatch and edema impair oxygenation and may produce respiratory failure. Hypoxemia also worsens myocardial oxygen supply and systemic oxygen delivery.
  evidence:
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: hypoxaemia from severe ventilation-perfusion mismatching in the lungs
  downstream:
  - target: Left Ventricular Contractile Dysfunction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Hypoxemia can impair myocardial function; this is one of several proposed contributors.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: The third stage then follows with LV failure secondary to impaired LV filling, ischaemic injury to the myocardium, myocardial depressant effect (from amniotic fluid), and hypoxaemia from severe ventilation-perfusion mismatching in the lungs
      explanation: The source presents a proposed staged model, not serial proof of an obligatory sequence.
      directness: INDIRECT
  - target: Maternal Tissue Oxygen Deprivation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Reduced arterial oxygenation compromises tissue oxygen delivery.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: The goals are the rapid correction of haemodynamic instability and hypoxia, preventing additional hypoxia and end-organ failure
      directness: INDIRECT
  - target: Fetal Oxygen Deprivation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Maternal hypoxemia can reduce fetal oxygen delivery.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: The foetus becomes more hypoxaemia, eventually ending in foetal demise.
      explanation: The review describes a possible severe outcome; not all fetuses die.
      directness: INDIRECT
    - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: as oxygenated blood is shunted away from the uterus
      explanation: Guideline synthesis of fetal perfusion compromise.
      directness: INDIRECT
  - target: Acute Hypoxaemia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Impaired oxygen transfer manifests as hypoxemia.
    evidence:
    - reference: PMID:28188959
      reference_title: 'Amniotic fluid embolism: Pathophysiology from the perspective of pathology.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: characterized by the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy
      quote_role: REVIEW_SYNTHESIS
      directness: INDIRECT
  - target: Dyspnoea
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Respiratory compromise can manifest as dyspnea.
    evidence:
    - reference: PMID:25807263
      reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: acute hypoxia (with dyspnoea, cyanosis and/or respiratory arrest)
      quote_role: REVIEW_SYNTHESIS
      directness: INDIRECT
  - target: Cyanosis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Severe arterial desaturation can produce cyanosis.
    evidence:
    - reference: PMID:25807263
      reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: with dyspnoea, cyanosis and/or respiratory arrest
      quote_role: REVIEW_SYNTHESIS
      directness: INDIRECT
  - target: Respiratory Failure Requiring Ventilatory Support
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Severe gas-exchange failure can require ventilation.
    evidence:
    - reference: PMID:26703453
      reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: '| Intubation/Ventilation | | 14 (42 %) |'
      explanation: Table 4 reports the intervention directly.
      directness: INDIRECT
- name: Coagulation Cascade Activation
  biological_scale: MOLECULAR
  description: Elevated prothrombin fragment 1+2 supports thrombin generation in selected AFE patients with DIC. The Japanese comparison included 27 pretransfusion samples selected from 789 DIC cases among 2059 registry reports; it does not establish DIC frequency in unselected AFE or identify the initiating tissue-factor activity.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: PF1 + 2 and PIC levels were higher in the AFE and sPA groups compared to the control group; however, there was no significant difference between the AFE and sPA groups
  conforms_to: thrombogenesis#Coagulation Cascade Activation and Thrombin-Driven Fibrin Formation
  downstream:
  - target: Excessive Plasmin Generation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Fibrin formation can recruit fibrinolysis; additional activation routes are possible, but the correlation study cannot determine independence.
    evidence:
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: PF1 + 2 and PIC were markedly increased in both AFE (n = 27) and severe PA (n = 12) compared to controls (n = 23), without significant difference between those disease groups
      directness: INDIRECT
  - target: Reduced Functional Fibrinogen
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Consumption during activated coagulation is one possible contributor to reduced functional fibrinogen.
    evidence:
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group
      directness: INDIRECT
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study.
      directness: INDIRECT
  - target: Disseminated Intravascular Coagulation
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Coagulation activation contributes to the clinical coagulopathy syndrome.
    evidence:
    - reference: PMID:26703453
      reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: '| | Coagulopathy | 24 (73 %) |'
      explanation: Associated feature among 33 prospectively reported cases, using a broader case definition.
      directness: INDIRECT
    - reference: PMID:27372270
      reference_title: Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Documentation of overt disseminated intravascular coagulation (DIC) using the scoring system
      explanation: DIC is part of the strict research definition, rather than an independent prevalence observation.
      directness: INDIRECT
  - target: Thrombocytopenia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Platelet consumption can contribute to thrombocytopenia, but the measured deficit has multiple possible contributors.
    evidence:
    - reference: PMID:26703453
      reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: '| | Platelets <100 10 9 /L | 20 (61 %) |'
      explanation: Worst recorded value in Table 4.
      directness: INDIRECT
    - reference: PMID:32157417
      reference_title: 'Amniotic fluid embolism-associated coagulopathy: a single-center observational study.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced
      explanation: Three cases only.
      directness: INDIRECT
- name: Excessive Plasmin Generation
  biological_scale: MOLECULAR
  description: Elevated plasmin–antiplasmin complexes and fibrin degradation markers support excessive fibrinolysis in selected coagulopathic cases. The absence of a significant PF1+2–PIC correlation within 27 AFE samples does not prove independence from coagulation or a difference from the comparator correlation. Samples followed variable blood loss and fluid administration.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: PF1 + 2 and PIC were markedly increased in both AFE (n = 27) and severe PA (n = 12) compared to controls (n = 23), without significant difference between those disease groups
  downstream:
  - target: Reduced Functional Fibrinogen
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Fibrinogen degradation and interference with polymerization may further lower measured function; the study did not separate these processes.
    evidence:
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group
      directness: INDIRECT
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study.
      directness: INDIRECT
- name: Reduced Functional Fibrinogen
  biological_scale: MOLECULAR
  description: Severely reduced Clauss fibrinogen can reflect consumption, degradation and impaired fibrin polymerization. Their separate contributions were not quantified in the selected Japanese cohort, which did not measure fibrinogen antigen or a functional-to-antigen ratio.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study.
  downstream:
  - target: Impaired Hemostasis
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Reduced functional fibrinogen compromises clot formation and bleeding control.
    evidence:
    - reference: PMID:32157417
      reference_title: 'Amniotic fluid embolism-associated coagulopathy: a single-center observational study.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: Disproportionately low levels of fibrinogen and factor five, and exorbitantly elevated D-dimers were present in all cases, whereas markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced.
      explanation: Three consecutive cases, not a universal phenotype.
      directness: INDIRECT
  - target: Hypofibrinogenaemia
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Reduced measured functional fibrinogen corresponds to this laboratory phenotype.
    evidence:
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group
      directness: INDIRECT
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: PRIMARY_RESULT
      snippet: We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study.
      directness: INDIRECT
- name: Impaired Hemostasis
  biological_scale: ORGANISM
  description: Loss of functional fibrinogen, other clotting-factor deficits and platelet abnormalities impair hemostasis and can produce severe obstetric or diffuse bleeding. The degree of thrombocytopenia varies; three relatively platelet-preserved cases do not define the whole disease.
  evidence:
  - reference: PMID:32157417
    reference_title: 'Amniotic fluid embolism-associated coagulopathy: a single-center observational study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Disproportionately low levels of fibrinogen and factor five, and exorbitantly elevated D-dimers were present in all cases, whereas markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced.
    explanation: Three consecutive cases, not a universal phenotype.
  downstream:
  - target: Reduced Systemic Perfusion
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Severe blood loss can worsen systemic hypoperfusion.
    evidence:
    - reference: PMID:35840499
      reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: thus predisposing to subsequent PPH, further haemodynamic instability
      directness: INDIRECT
  - target: Postpartum Haemorrhage
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Impaired hemostasis exacerbates bleeding after delivery.
    evidence:
    - reference: PMID:24888909
      reference_title: 'Amniotic fluid embolism: pathophysiology and new strategies for management.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: the presence of disseminated intravascular coagulation (DIC) and atonic bleeding
      quote_role: REVIEW_SYNTHESIS
      directness: INDIRECT
- name: Maternal Tissue Oxygen Deprivation
  biological_scale: ORGANISM
  description: Reduced systemic perfusion and hypoxemia compromise tissue oxygen delivery, potentially contributing to cerebral and other organ injury. Individual seizures or focal cerebral infarctions are not fully explained by this general pathway.
  evidence:
  - reference: PMID:35840499
    reference_title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The goals are the rapid correction of haemodynamic instability and hypoxia, preventing additional hypoxia and end-organ failure
  downstream:
  - target: Seizures
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Cerebral oxygen deprivation can contribute to seizures, without explaining every episode.
    evidence:
    - reference: PMID:28188959
      reference_title: 'Amniotic fluid embolism: Pathophysiology from the perspective of pathology.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy (DIC)
      quote_role: REVIEW_SYNTHESIS
      directness: INDIRECT
  - target: Coma
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Severe cerebral oxygen deprivation can impair consciousness.
    evidence:
    - reference: PMID:25807263
      reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: coagulopathies (disseminated intravascular coagulation and/or severe hemorrhage), coma and seizures
      quote_role: REVIEW_SYNTHESIS
      directness: INDIRECT
  - target: Acute Kidney Injury
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: Hypoperfusion can contribute to renal injury; disease-specific intermediates are unresolved.
    evidence:
    - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK559107/
      reference_title: Amniotic Fluid Embolism - StatPearls - NCBI Bookshelf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: acute renal failure due to acute tubular necrosis
      directness: INDIRECT
- name: Fetal Oxygen Deprivation
  biological_scale: ORGANISM
  description: Maternal cardiopulmonary compromise can reduce oxygen delivery to a fetus still in utero. This downstream fetal consequence is conditional on timing; neonatal outcomes also depend on gestation and other conditions.
  evidence:
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: Fetal heart rate abnormalities are a common presenting feature of AFE,
    explanation: Clinical interpretation of fetal compromise in a prospective maternal cohort.
  - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: as oxygenated blood is shunted away from the uterus
    explanation: Guideline synthesis of fetal perfusion compromise.
phenotypes:
- category: Cardiovascular
  name: Cardiac Arrest
  description: Cardiac arrest can occur during acute collapse but is not present in every case. The prospective Australasian study recorded associated arrest in 13/33; its CPR table reports 14/33 and the abstract contains a discordant count, so arrest and resuscitation counts are not treated as interchangeable.
  phenotype_term:
    preferred_term: Cardiac arrest
    term:
      id: HP:0001695
      label: Cardiac arrest
    temporality: ACUTE
  evidence:
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| | Cardiac arrest | 13 (39 %) |'
    explanation: Table 3, associated features among 33 reported cases.
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Cardiac arrest accompanies many cases of AFE, but not all
- category: Cardiovascular
  name: Profound Hypotension
  description: Sudden systemic hypotension is a major clinical feature. In the voluntary US-based registry, recorded hypotension occurred in 54/54 typical and 8/10 atypical cases with available data; case definition and missing data preclude a population frequency.
  phenotype_term:
    preferred_term: Hypotension
    term:
      id: HP:0002615
      label: Hypotension
    severity: SEVERE
    temporality: ACUTE
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| Hypotension | 54/54 (100.0) | 8/10 (80.0) | 0.001 |'
    explanation: Table 3; selected typical and atypical groups with available observations.
- category: Respiratory
  name: Acute Hypoxaemia
  description: "Abrupt hypoxaemia, one of the three cardinal features required by most research case definitions.\n"
  phenotype_term:
    preferred_term: Hypoxemia
    term:
      id: HP:0012418
      label: Hypoxemia
    temporality: ACUTE
  evidence:
  - reference: PMID:28188959
    reference_title: 'Amniotic fluid embolism: Pathophysiology from the perspective of pathology.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: characterized by the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy
    quote_role: REVIEW_SYNTHESIS
- category: Respiratory
  name: Dyspnoea
  phenotype_term:
    preferred_term: Dyspnea
    term:
      id: HP:0002094
      label: Dyspnea
    temporality: ACUTE
  evidence:
  - reference: PMID:25807263
    reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: acute hypoxia (with dyspnoea, cyanosis and/or respiratory arrest)
    quote_role: REVIEW_SYNTHESIS
- category: Respiratory
  name: Cyanosis
  phenotype_term:
    preferred_term: Cyanosis
    term:
      id: HP:0000961
      label: Cyanosis
    temporality: ACUTE
  evidence:
  - reference: PMID:25807263
    reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: with dyspnoea, cyanosis and/or respiratory arrest
    quote_role: REVIEW_SYNTHESIS
- category: Respiratory
  name: Pulmonary Oedema
  description: Pulmonary edema occurs in AFE. Registry Table 3 records 9/46 typical and 5/10 atypical cases; its narrative reverses the apparent group direction. The observation supports presence, not a validated marker of AFE severity.
  phenotype_term:
    preferred_term: Pulmonary edema
    term:
      id: HP:0100598
      label: Pulmonary edema
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| Pulmonary Edema | 9/46 (19.6) | 5/10 (50.0) | 0.04 |'
    explanation: Exact table counts; the narrative comparison is inconsistent.
- category: Hematologic
  name: Disseminated Intravascular Coagulation
  description: Coagulopathy may accompany collapse or become apparent afterward, with occasional predominantly hemorrhagic presentations. DIC is required by some research definitions and by the inclusion criteria of mechanistic cohorts; their high rates cannot establish a disease-wide frequency.
  phenotype_term:
    preferred_term: Disseminated intravascular coagulation
    term:
      id: HP:0005521
      label: Disseminated intravascular coagulation
  evidence:
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| | Coagulopathy | 24 (73 %) |'
    explanation: Associated feature among 33 prospectively reported cases, using a broader case definition.
  - reference: PMID:27372270
    reference_title: Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Documentation of overt disseminated intravascular coagulation (DIC) using the scoring system
    explanation: DIC is part of the strict research definition, rather than an independent prevalence observation.
- category: Hematologic
  name: Hypofibrinogenaemia
  description: Clauss fibrinogen was markedly reduced in the selected Japanese AFE-with-DIC cohort (median 0.50 g/L, range 0.20–1.59). This functional assay cannot distinguish fibrinogen depletion from all possible polymerization defects.
  phenotype_term:
    preferred_term: Hypofibrinogenemia
    term:
      id: HP:0011900
      label: Hypofibrinogenemia
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study.
- category: Hematologic
  name: Thrombocytopenia
  description: Platelet counts can fall substantially; the Australasian cohort recorded counts below 100 × 10^9/L in 20/33. A separate three-case series found only mild reductions, so relative platelet preservation is not a universal property.
  phenotype_term:
    preferred_term: Thrombocytopenia
    term:
      id: HP:0001873
      label: Thrombocytopenia
  evidence:
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| | Platelets <100 10 9 /L | 20 (61 %) |'
    explanation: Worst recorded value in Table 4.
  - reference: PMID:32157417
    reference_title: 'Amniotic fluid embolism-associated coagulopathy: a single-center observational study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: markers of consumptive coagulopathy, platelets and antithrombin in particular, were only slightly reduced
    explanation: Three cases only.
- category: Obstetric
  name: Postpartum Haemorrhage
  description: Severe postpartum bleeding may reflect coagulopathy and uterine atony, with possible additional obstetric bleeding sources. In the selected Japanese DIC cohort, 23/27 had postpartum hemorrhage; the presence of hemorrhage alone is insufficient to diagnose AFE.
  phenotype_term:
    preferred_term: Post-partum hemorrhage
    term:
      id: HP:0011891
      label: Post-partum hemorrhage
    severity: SEVERE
  evidence:
  - reference: PMID:24888909
    reference_title: 'Amniotic fluid embolism: pathophysiology and new strategies for management.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: the presence of disseminated intravascular coagulation (DIC) and atonic bleeding
    quote_role: REVIEW_SYNTHESIS
- category: Neurologic
  name: Seizures
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
    temporality: ACUTE
  evidence:
  - reference: PMID:28188959
    reference_title: 'Amniotic fluid embolism: Pathophysiology from the perspective of pathology.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: the abrupt onset of hypoxia, hypotension, seizures, or disseminated intravascular coagulopathy (DIC)
    quote_role: REVIEW_SYNTHESIS
- category: Neurologic
  name: Coma
  phenotype_term:
    preferred_term: Coma
    term:
      id: HP:0001259
      label: Coma
    temporality: ACUTE
  evidence:
  - reference: PMID:25807263
    reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: coagulopathies (disseminated intravascular coagulation and/or severe hemorrhage), coma and seizures
    quote_role: REVIEW_SYNTHESIS
- category: Neurologic
  name: Cerebral Infarction in Survivors
  description: A linked population cohort reported increased cerebral infarction among survivors. Focal ischemic stroke should be distinguished from diffuse post-arrest hypoxic brain injury; this association does not identify the vascular mechanism in each patient.
  phenotype_term:
    preferred_term: Cerebral infarction
    term:
      id: HP:0002140
      label: Ischemic stroke
  evidence:
  - reference: PMID:21126320
    reference_title: Amniotic fluid embolism in an Australian population-based cohort.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: survivors were at increased risk of cerebral infarction
    quote_role: PRIMARY_RESULT
- category: Respiratory
  name: Respiratory Failure Requiring Ventilatory Support
  phenotype_term:
    preferred_term: Respiratory failure
    term:
      id: HP:0002878
      label: Respiratory failure
    temporality: ACUTE
  evidence:
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| Intubation/Ventilation | | 14 (42 %) |'
    explanation: Table 4 reports the intervention directly.
  description: Respiratory failure may require intubation and mechanical ventilation. The prospective Australasian cohort recorded intubation/ventilation in 14/33; ICU admission alone is not evidence that a patient was ventilated.
- name: Bronchospasm
  category: Respiratory
  description: Bronchospasm was recorded in 5/34 typical and 2/10 atypical registry cases with available data. It is neither universal nor specific to AFE.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| Bronchospasm | 5/34 (14.7) | 2/10 (20.0) | 0.7 |'
    explanation: Selected voluntary registry, variable available-data denominators; no population frequency inferred.
  phenotype_term:
    preferred_term: Bronchoconstriction
    term:
      id: HP:4000007
      label: Bronchoconstriction
- name: Chest Pain
  category: Cardiovascular
  description: Chest pain was recorded in 6/48 typical and 3/13 atypical registry cases with available data.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| Chest Pain | 6/48 (12.5) | 3/13 (23.1) | 0.3 |'
    explanation: Selected voluntary registry, variable available-data denominators; no population frequency inferred.
  phenotype_term:
    preferred_term: Chest pain
    term:
      id: HP:0100749
      label: Chest pain
- name: Cough
  category: Respiratory
  description: Cough was recorded in 2/48 typical and 2/13 atypical registry cases with available data.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| Cough | 2/48 (4.1) | 2/13 (15.4) | 0.1 |'
    explanation: Selected voluntary registry, variable available-data denominators; no population frequency inferred.
  phenotype_term:
    preferred_term: Cough
    term:
      id: HP:0012735
      label: Cough
- name: Headache
  category: Neurologic
  description: Headache was recorded in 3/50 typical and 4/13 atypical registry cases with available data. It is nonspecific and does not by itself establish a causal neurologic mechanism.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| Headache | 3/50 (6.0) | 4/13 (30.8) | 0.01 |'
    explanation: Selected voluntary registry, variable available-data denominators; no population frequency inferred.
  phenotype_term:
    preferred_term: Headache
    term:
      id: HP:0002315
      label: Headache
- name: Uterine Atony
  category: Obstetric
  description: Uterine atony can compound obstetric bleeding. It was recorded in 28/51 typical and 3/11 atypical registry cases with available data. No specific HPO term for uterine atony was found; a generic uterine abnormality binding would lose this distinction.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| Uterine Atony | 28/51 (54.9) | 3/11 (27.2) | 0.1 |'
    explanation: Selected voluntary registry, variable available-data denominators; no population frequency inferred.
- name: Acute Kidney Injury
  category: Renal
  description: Acute renal failure is a reported severe complication. Hemodynamic compromise and other critical-illness mechanisms may contribute; it is not established in every case.
  evidence:
  - reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK559107/
    reference_title: Amniotic Fluid Embolism - StatPearls - NCBI Bookshelf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: acute renal failure due to acute tubular necrosis
  phenotype_term:
    preferred_term: Acute kidney injury
    term:
      id: HP:0001919
      label: Acute kidney injury
- name: Cardiac Arrhythmia
  category: Cardiovascular
  description: Abnormal cardiac rhythm was recorded in 8/33 Australasian cases as an associated feature; rhythms and temporal patterns vary.
  evidence:
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: '| | Abnormal cardiac rhythm | 8 (24 %) |'
    explanation: Table3 associated features; no disease-wide frequency inferred.
  phenotype_term:
    preferred_term: Arrhythmia
    term:
      id: HP:0011675
      label: Arrhythmia
treatments:
- name: Immediate Cardiopulmonary Resuscitation
  therapeutic_modality: OTHER
  description: For cardiac arrest, begin high-quality CPR and standard advanced life support immediately while the obstetric emergency team responds; diagnosis must not delay resuscitation. Relieve aortocaval compression with manual lateral uterine displacement. The 2016 SMFM recommendation was GRADE 1C; the 2026 checklist reinforces pregnancy-specific resuscitation.
  evidence:
  - reference: PMID:26987420
    reference_title: 'Amniotic fluid embolism: diagnosis and management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: we recommend the provision of immediate high-quality cardiopulmonary resuscitation with standard basic cardiac life support and advanced cardiac life support protocols in patients who develop cardiac arrest associated with amniotic fluid embolism
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Priorities for pregnant people in cardiac arrest should include the provision of high‐quality cardiopulmonary resuscitation (CPR) and relief of aortocaval compression with lateral uterine displacement
  treatment_term:
    preferred_term: resuscitation
    term:
      id: NCIT:C50822
      label: Resuscitation
  target_mechanisms:
  - target: Reduced Systemic Perfusion
    treatment_effect: BYPASSES
    description: Chest compressions provide temporary circulation during arrest.
    evidence:
    - reference: PMID:26987420
      reference_title: 'Amniotic fluid embolism: diagnosis and management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: we recommend the provision of immediate high-quality cardiopulmonary resuscitation with standard basic cardiac life support and advanced cardiac life support protocols in patients who develop cardiac arrest associated with amniotic fluid embolism
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Priorities for pregnant people in cardiac arrest should include the provision of high‐quality cardiopulmonary resuscitation (CPR) and relief of aortocaval compression with lateral uterine displacement
- name: Vasopressor Support
  therapeutic_modality: SMALL_MOLECULE
  description: Use vasopressors when hypotension requires support, guided by hemodynamic status. Severe right ventricular compromise favors pressure support over indiscriminate fluid loading; bleeding still requires appropriate blood-product resuscitation.
  evidence:
  - reference: PMID:31376394
    reference_title: 'Amniotic fluid embolism: principles of early clinical management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Blood pressure support with vasopressors is preferred over fluid infusion in the setting of severe right ventricular compromise.
  target_mechanisms:
  - target: Reduced Systemic Perfusion
    treatment_effect: MODULATES
    description: Supports pressure and organ perfusion without correcting the initiating insult.
    evidence:
    - reference: PMID:31376394
      reference_title: 'Amniotic fluid embolism: principles of early clinical management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Blood pressure support with vasopressors is preferred over fluid infusion in the setting of severe right ventricular compromise.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: noradrenaline
      term:
        id: CHEBI:33569
        label: noradrenaline
- name: Inotropic Support
  therapeutic_modality: SMALL_MOLECULE
  description: Use echo-guided inotropic support for significant ventricular dysfunction. Dobutamine or milrinone may be selected by the critical-care team; no comparative AFE drug trial establishes a universally preferred agent.
  evidence:
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Inotropes and pulmonary vasodilators are the primary therapies; transthoracic or transesophageal echocardiography can be used to guide therapy.
  - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: inotropes (dobutamine or milrinone) to increase left ventricular contractility.
  target_mechanisms:
  - target: Acute Right Ventricular Failure
    treatment_effect: MODULATES
    description: Supports contractile performance of a failing right ventricle.
    evidence:
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Inotropes and pulmonary vasodilators are the primary therapies; transthoracic or transesophageal echocardiography can be used to guide therapy.
  - target: Left Ventricular Contractile Dysfunction
    treatment_effect: MODULATES
    description: Supports left ventricular contractility when impaired.
    evidence:
    - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: inotropes (dobutamine or milrinone) to increase left ventricular contractility.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: dobutamine
      term:
        id: CHEBI:4670
        label: dobutamine
    - preferred_term: milrinone
      term:
        id: CHEBI:50693
        label: milrinone
- name: Pulmonary Vasodilator Therapy
  therapeutic_modality: SMALL_MOLECULE
  description: Consider pulmonary vasodilators to reduce right ventricular afterload in documented pulmonary hypertension/right ventricular failure, under expert hemodynamic monitoring. Inhaled nitric oxide or prostacyclin are options; use is targeted rather than routine for every respiratory presentation.
  evidence:
  - reference: PMID:31376394
    reference_title: 'Amniotic fluid embolism: principles of early clinical management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: If such failure is identified, treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: inhaled nitric oxide
      term:
        id: CHEBI:16480
        label: nitric oxide
  target_mechanisms:
  - target: Pulmonary Vasoconstriction
    treatment_effect: INHIBITS
    description: Reduces pulmonary vasoconstriction and ventricular afterload.
    evidence:
    - reference: PMID:31376394
      reference_title: 'Amniotic fluid embolism: principles of early clinical management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: If such failure is identified, treatment that is tailored at improving right ventricular performance should be initiated with the use of inotropic agents and pulmonary vasodilators.
- name: Hemostatic Resuscitation and Fibrinogen Replacement
  therapeutic_modality: OTHER
  description: Activate the massive transfusion protocol for severe bleeding and assess coagulation early. Replace red cells, plasma and platelets according to the evolving deficit, with prompt fibrinogen replacement using cryoprecipitate or locally appropriate concentrates. The 2026 checklist describes approximately 1:1:1 component resuscitation and favors concentrated cryoprecipitate for fibrinogen support to limit volume overload; this does not replace every plasma indication. Avoid excessive crystalloid or colloid loading.
  evidence:
  - reference: PMID:26987420
    reference_title: 'Amniotic fluid embolism: diagnosis and management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: in AFE, cryoprecipitate is favored over fresh or frozen plasma to limit the risk of volume overload while addressing coagulopathy
  treatment_term:
    preferred_term: blood transfusion
    term:
      id: NCIT:C15192
      label: Blood Transfusion
  target_mechanisms:
  - target: Reduced Functional Fibrinogen
    treatment_effect: RESTORES
    description: Replaces deficient functional fibrinogen.
    evidence:
    - reference: PMID:26987420
      reference_title: 'Amniotic fluid embolism: diagnosis and management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: in AFE, cryoprecipitate is favored over fresh or frozen plasma to limit the risk of volume overload while addressing coagulopathy
  - target: Impaired Hemostasis
    treatment_effect: RESTORES
    description: Replaces deficient hemostatic components while bleeding sources are controlled.
    evidence:
    - reference: PMID:26987420
      reference_title: 'Amniotic fluid embolism: diagnosis and management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: in AFE, cryoprecipitate is favored over fresh or frozen plasma to limit the risk of volume overload while addressing coagulopathy
- name: Tranexamic Acid
  therapeutic_modality: SMALL_MOLECULE
  description: The 2026 SMFM checklist includes tranexamic acid for AFE-associated DIC or hemorrhage. It suppresses fibrinolysis and accompanies blood-product resuscitation and source control. The observational AFE biomarker study did not test treatment efficacy; do not infer an AFE-specific survival effect from its mechanistic rationale.
  evidence:
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: including the use of uterotonic agents, administration of tranexamic acid
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: BACKGROUND
    snippet: Tranexamic acid, a universally available antifibrinolytic agent, inhibits plasminogen from binding with fibrin and suppresses production of plasmin
    explanation: Background pharmacology in the observational study.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: tranexamic acid
      term:
        id: CHEBI:48669
        label: tranexamic acid
  target_mechanisms:
  - target: Excessive Plasmin Generation
    treatment_effect: INHIBITS
    description: Limits plasmin generation and fibrin-associated fibrinolysis.
    evidence:
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: including the use of uterotonic agents, administration of tranexamic acid
    - reference: PMID:38168649
      reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: BACKGROUND
      snippet: Tranexamic acid, a universally available antifibrinolytic agent, inhibits plasminogen from binding with fibrin and suppresses production of plasmin
      explanation: Background pharmacology in the observational study.
- name: Resuscitative Delivery During Maternal Cardiac Arrest
  therapeutic_modality: SURGERY
  description: Prepare for immediate delivery during maternal arrest; the 2026 checklist calls for cesarean delivery to be started within 4 minutes when circulation has not returned. Uterine evacuation can improve maternal hemodynamics as well as fetal outcome. Perform it where the patient is located if transfer would delay treatment. Operative vaginal delivery is an option only when complete dilation and a crowning head allow prompt birth. Apply the pregnancy cardiac-arrest protocol and individual clinical circumstances; the older 2016 guideline used a fetal viability threshold of 23 weeks.
  evidence:
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Immediate delivery can improve maternal hemodynamics and, in a patient receiving CPR, should be initiated within 4 min to increase the likelihood of return of spontaneous circulation
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Operative vaginal delivery can be considered if the cervix is completely dilated and the fetal head is crowning
  treatment_term:
    preferred_term: cesarean section
    term:
      id: NCIT:C46088
      label: Cesarean Section
  target_mechanisms:
  - target: Reduced Systemic Perfusion
    treatment_effect: MODULATES
    description: Relieves gravid uterine compression during maternal resuscitation.
    evidence:
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Immediate delivery can improve maternal hemodynamics and, in a patient receiving CPR, should be initiated within 4 min to increase the likelihood of return of spontaneous circulation
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Operative vaginal delivery can be considered if the cervix is completely dilated and the fetal head is crowning
  - target: Fetal Oxygen Deprivation
    treatment_effect: BYPASSES
    description: Delivery permits direct neonatal support when fetal oxygen delivery is compromised.
    evidence:
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Immediate delivery can improve maternal hemodynamics and, in a patient receiving CPR, should be initiated within 4 min to increase the likelihood of return of spontaneous circulation
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Operative vaginal delivery can be considered if the cervix is completely dilated and the fetal head is crowning
- name: Venoarterial Extracorporeal Membrane Oxygenation
  therapeutic_modality: DEVICE
  description: Consider VA-ECMO for prolonged arrest or severe ventricular failure refractory to medical management at an experienced center. Coagulopathy does not automatically exclude support, but cannulation and anticoagulation require individualized bleeding-risk management. Published cases are selected and cannot establish comparative survival benefit.
  evidence:
  - reference: PMID:31376394
    reference_title: 'Amniotic fluid embolism: principles of early clinical management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given.
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: For hemodynamically refractory cases, extracorporeal membrane oxygenation can be considered, even in the context of coagulopathy
  treatment_term:
    preferred_term: extracorporeal membrane oxygenation
    term:
      id: NCIT:C171507
      label: Extracorporeal Membrane Oxygenation
  target_mechanisms:
  - target: Reduced Systemic Perfusion
    treatment_effect: BYPASSES
    description: Provides temporary extracorporeal circulatory support.
    evidence:
    - reference: PMID:31376394
      reference_title: 'Amniotic fluid embolism: principles of early clinical management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given.
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: For hemodynamically refractory cases, extracorporeal membrane oxygenation can be considered, even in the context of coagulopathy
  - target: Impaired Pulmonary Gas Exchange
    treatment_effect: BYPASSES
    description: Provides extracorporeal gas exchange.
    evidence:
    - reference: PMID:31376394
      reference_title: 'Amniotic fluid embolism: principles of early clinical management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: In cases that require prolonged cardiopulmonary resuscitation or, after arrest, severe ventricular dysfunction refractory to medical management, consideration for venoarterial extracorporeal membrane oxygenation should be given.
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: For hemodynamically refractory cases, extracorporeal membrane oxygenation can be considered, even in the context of coagulopathy
- name: Oxygenation and Ventilatory Support
  therapeutic_modality: DEVICE
  description: Provide oxygen and assisted ventilation as required by respiratory status, including airway protection and mechanical ventilation when needed. Avoid hypoxemia and excessive ventilation; after arrest, titrate oxygen rather than maintaining unnecessary hyperoxia.
  evidence:
  - reference: PMID:26987420
    reference_title: 'Amniotic fluid embolism: diagnosis and management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: we recommend the provision of adequate oxygenation and ventilation
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: starting 100% oxygen, obtaining intravenous access, and providing ventilation with bag‐mask support or endotracheal intubation
  - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: The inspired fraction of oxygen should be weaned to maintain a pulse oxymetry value of 94-98%.
  treatment_term:
    preferred_term: mechanical ventilation
    term:
      id: NCIT:C70909
      label: Mechanical Ventilation
  target_mechanisms:
  - target: Impaired Pulmonary Gas Exchange
    treatment_effect: BYPASSES
    description: Supports oxygenation while the pulmonary and cardiovascular insult is treated.
    evidence:
    - reference: PMID:26987420
      reference_title: 'Amniotic fluid embolism: diagnosis and management.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: we recommend the provision of adequate oxygenation and ventilation
    - reference: PMID:42730345
      reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: starting 100% oxygen, obtaining intravenous access, and providing ventilation with bag‐mask support or endotracheal intubation
- name: Control of Uterine Atony and Other Bleeding Sources
  therapeutic_modality: OTHER
  description: Use uterotonics, examine for genital tract trauma and address obstetric sources of hemorrhage while correcting coagulopathy. Refractory atony may require balloon tamponade, compression sutures, arterial control or hysterectomy. These are severity-dependent escalation options, not universal treatment requirements.
  evidence:
  - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Uterine atony is common with amniotic fluid embolism and should be managed aggressively.
  - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Extreme cases may need bilateral uterine artery ligation, B-Lynch stitch, or hysterectomy.
  target_mechanisms:
  - target: Uterine Atony
    treatment_effect: MODULATES
    description: Uterotonics and mechanical or surgical control improve uterine bleeding control.
    evidence:
    - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Uterine atony is common with amniotic fluid embolism and should be managed aggressively.
    - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Extreme cases may need bilateral uterine artery ligation, B-Lynch stitch, or hysterectomy.
  - target: Postpartum Haemorrhage
    treatment_effect: INHIBITS
    description: Treats concurrent obstetric bleeding sources.
    evidence:
    - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      quote_role: REVIEW_SYNTHESIS
      snippet: Uterine atony is common with amniotic fluid embolism and should be managed aggressively.
    - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
      supports: SUPPORT
      evidence_source: OTHER
      quote_role: REVIEW_SYNTHESIS
      snippet: Extreme cases may need bilateral uterine artery ligation, B-Lynch stitch, or hysterectomy.
- name: Psychological Support and Post-Event Follow-Up
  therapeutic_modality: OTHER
  description: Assess physical recovery, neurologic deficits and mental health after severe maternal illness. Offer trauma-informed support and referral for persistent post-traumatic stress or depression symptoms. Discuss subsequent pregnancies individually because reassuring small series do not establish zero recurrence risk.
  evidence:
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: the need for psychological and emotional support for the patient, family members, and clinical staff should be recognized.
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: All of the patients who reported post-traumatic stress symptoms were surveyed about their mental health resources and were referred to local facilities for mental health care.
- name: Avoid Routine Atropine-Ondansetron-Ketorolac Regimen
  therapeutic_modality: OTHER
  description: 'The corrected 2026 SMFM statement reports an expert recommendation against routine AOK treatment: evidence is limited to case reports and potential harms include renal dysfunction, bleeding, arrhythmia and myocardial injury. Atropine is not a routine AFE treatment in the absence of bradycardia.'
  evidence:
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: recommends against the routine use of the atropine, ondansetron, and ketorolac regimen.
- name: C1 Esterase Inhibitor Replacement (Investigational)
  therapeutic_modality: OTHER
  description: Reduced endogenous activity supplies a research rationale, but no cited controlled study establishes that replacement improves AFE outcomes. It is not standard resuscitative therapy and should not be represented as proven reversal of an established causal deficiency.
  evidence:
  - reference: PMID:24888909
    reference_title: 'Amniotic fluid embolism: pathophysiology and new strategies for management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: C1 esterase inhibitor may be a promising candidate of treatment of AFE.
    explanation: Author-proposed therapy, not an efficacy finding.
diagnosis:
- name: Clinical Diagnosis and Immediate Differential Assessment
  description: AFE is a clinical diagnosis in sudden peripartum cardiopulmonary compromise with coagulopathy after considering alternative causes. Resuscitation proceeds while the differential is evaluated. No individual laboratory assay, fetal squame finding or cytokine result can currently confirm or exclude AFE.
  evidence:
  - reference: PMID:26987420
    reference_title: 'Amniotic fluid embolism: diagnosis and management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: we do not recommend the use of any specific diagnostic laboratory test to either confirm or refute the diagnosis of amniotic fluid embolism; at the present time, amniotic fluid embolism remains a clinical diagnosis
- name: Strict Criteria for Research Reporting
  description: The 2016 research definition requires sudden arrest, or hypotension with respiratory compromise; overt DIC before blood loss sufficient to explain the coagulopathy; onset during labor or within 30 minutes of placental delivery; and no intrapartum fever of 38°C or higher. These criteria deliberately exclude some atypical clinical cases and should not be used to delay support or automatically rule out clinical AFE. In 115 selected registry charts, 54 fulfilled the criteria and 14 additional cases were considered AFE by expert review; the comparator was expert consensus, not a diagnostic gold standard.
  evidence:
  - reference: PMID:27372270
    reference_title: Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: This approach is intended to apply only to patients included in research reports
  - reference: PMID:30481492
    reference_title: Evaluation of proposed criteria for research reporting of amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: The 14 cases (21%) identified by the expert panel as AFE that did not meet the objective criteria are believed to represent atypical presentations of this condition.
- name: Echocardiography to Characterize Hemodynamic Failure
  description: Bedside transthoracic or transesophageal echocardiography assesses right and left ventricular function, septal displacement and pulmonary hypertension to guide therapy and evaluate alternative cardiac causes. The pattern is not independently diagnostic of AFE.
  evidence:
  - reference: PMID:31376394
    reference_title: 'Amniotic fluid embolism: principles of early clinical management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: we recommend performing transthoracic or transesophageal echocardiography as soon as possible because this is an easy and reliable method of identifying a failing right ventricle.
  diagnosis_term:
    preferred_term: Echocardiography Test
    term:
      id: NCIT:C16525
      label: Echocardiography Test
- name: Serial Coagulation and Organ-Function Assessment
  description: Assess blood count, platelets, fibrinogen, coagulation times, blood gases and organ function early and repeatedly as clinically indicated. Viscoelastic assays can assist rapid hemostatic management where available. These measurements guide support, rather than specifically identifying AFE.
  evidence:
  - reference: PMID:26987420
    reference_title: 'Amniotic fluid embolism: diagnosis and management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: we recommend the early assessment of clotting status and early aggressive management of clinical bleeding with standard massive transfusion protocols
differential_diagnoses:
- name: Postpartum hemorrhage with hypovolemic shock
  distinguishing_features:
  - Primary obstetric blood loss can produce shock and secondary dilutional or consumptive coagulopathy. Establish the sequence of bleeding, coagulopathy and cardiorespiratory collapse; hemorrhage alone does not establish AFE.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: the most common actual diagnosis was hypovolemic shock secondary to postpartum hemorrhage (n=21, 77.7%)
    explanation: Among 27 alternative diagnoses in a selected registry.
- name: Anesthetic complications
  distinguishing_features:
  - High neuraxial block or local-anesthetic systemic toxicity can cause abrupt respiratory or cardiovascular compromise. Timing relative to anesthetic administration and neurologic findings help distinguish these conditions; coagulopathy is not their usual initial feature.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: followed by anesthetic complications (n = 4, 14.8%)
- name: Sepsis
  distinguishing_features:
  - Infection can cause respiratory failure, cardiovascular collapse and DIC. Fever, infection evidence and time course inform the differential, but their absence does not by itself prove AFE.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: sepsis-related cardiovascular collapse (n = 2, 7.4%).
- name: Placental abruption with disseminated intravascular coagulation
  distinguishing_features:
  - Abruption can cause bleeding, fetal compromise and severe coagulopathy. PF1+2 and PIC elevations overlap with selected AFE cases; differences in correlations or tPA/TAFI antigen concentrations are not validated bedside discriminators.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Both AFE and sPA were associated with activation of coagulation and massive fibrinolysis without significant difference in each plasma maker between the groups.
- name: Pulmonary thromboembolism, myocardial infarction and air embolism
  distinguishing_features:
  - These are alternative causes of abrupt peripartum collapse requiring directed evaluation and treatment. Echocardiography, ECG and appropriate vascular imaging are selected according to clinical stability; right ventricular dysfunction alone does not prove AFE.
  evidence:
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: The differential diagnosis of AFE includes pulmonary embolism, myocardial infarction, air embolism, high spinal block, and sepsis.
- name: Anaphylaxis, eclampsia and peripartum cardiomyopathy
  distinguishing_features:
  - Drug exposure with rash or bronchospasm, hypertensive disease with seizures, or predominant left ventricular failure may favor these alternatives. No single clinical sign safely excludes competing causes of collapse.
  evidence:
  - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: includes myocardial infarction, pulmonary embolism, air embolism, anesthetic complications, anaphylaxis, and eclampsia and in some cases sepsis.
  - reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    reference_title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Echocardiography will also aid in ruling out conditions such as a peripartum dilated cardiomyopathy.
discussions:
- discussion_id: afe_case_definition
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: How do case definitions affect mechanistic and outcome estimates?
  rationale: Strict research criteria improve consistency but exclude some expert-adjudicated atypical cases. The 2020 voluntary registry classified 59/129 typical, 15 atypical, 27 alternative and 28 indeterminate; indeterminate does not mean a proven alternative diagnosis. A 2024 series selected 29 cases using broader proposed criteria, none meeting Clark criteria, without a gold-standard validation of the new definition. Different ascertainment and incomplete records limit pooled frequency and mortality interpretations.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: 22% (28/129) had an uncertain diagnosis.
  - reference: PMID:38082418
    reference_title: 'Amniotic fluid embolism: a reappraisal.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: None of the cases met Clark's criteria while all met our criteria.
- discussion_id: afe_complement_and_mast_cells
  kind: CONTROVERSY
  status: OPEN
  prompt: Which immune observations are causal rather than accompanying critical illness?
  rationale: Low C1 inhibitor activity and complement concentrations, pulmonary degranulation and occasional cytokine elevations supply hypotheses rather than an established ordered pathway. Serum and tissue tryptase measurements sample different compartments and times; negative serum findings in other cases do not refute local lung degranulation. Healthy controls alone do not resolve specificity against sepsis, anaphylaxis or hemorrhagic shock.
  evidence:
  - reference: PMID:25807263
    reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: the results obtained were negative for serum tryptase and urinary histamine measurements in women with AFE
  - reference: PMID:41765067
    reference_title: 'A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: BACKGROUND
    snippet: It is not known whether C1-INH dysregulation precedes clinical deterioration or reflects downstream consumption
  attaches_to:
  - pathophysiology#Complement Activation
  - pathophysiology#Reduced C1 Esterase Inhibitor Activity
  - pathophysiology#Pulmonary Mast Cell Degranulation
  - pathophysiology#Maternal Inflammatory Mediator Activation
- discussion_id: afe_coagulation_scope
  kind: INTERPRETATION
  status: OPEN
  prompt: What can the coagulation comparison establish?
  rationale: The 27 AFE samples were selected from 789 registry cases meeting Erez DIC criteria among 2059 reports. Sampling was before transfusion but after a median 4.9 L blood loss and 1.3 L administered fluid, with variable timing. Both thrombin-generation and plasmin-generation markers were elevated. A nonsignificant within-group correlation does not establish coagulation-independent fibrinolysis. Antigen assays do not quantify tPA or TAFIa activity. The graph represents coagulation activation and excessive fibrinolysis without asserting that occlusive microthrombi cannot form.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Among a total of 2059 cases enrolled in the Japanese AFE Registry, we identified 789 AFE patients who met the definition of DIC by Erez’s diagnostic criteria. Of these, plasma samples before blood transfusion were available for 27 cases.
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: We evaluated antigen levels, not activity, for the plasma tPA and total TAFI
  attaches_to:
  - pathophysiology#Coagulation Cascade Activation
  - pathophysiology#Excessive Plasmin Generation
  - pathophysiology#Reduced Functional Fibrinogen
- discussion_id: afe_risk_association
  kind: INTERPRETATION
  status: OPEN
  prompt: Do epidemiologic associations justify altering obstetric practice?
  rationale: Population studies report associations with medical induction, advanced maternal age and placental or delivery complications. These do not identify a deterministic cause; confounding, reverse causation and case misclassification remain possible. Absence of an actionable prevention rule does not refute an association. The Canadian three-million-delivery study reported adjusted odds 1.8 for medical induction with low absolute excess risk. Current clinical assessment should follow indications for obstetric care rather than an unvalidated AFE prevention strategy.
  evidence:
  - reference: PMID:17055946
    reference_title: 'Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Medical induction of labour nearly doubled the risk of overall cases of amniotic-fluid embolism (adjusted odds ratio 1.8 [1.3-2.7])
  - reference: PMID:24402585
    reference_title: Amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: at present, no putative risk factor has been identified that would justify modification of standard obstetric practice to reduce the risk of this condition.
- discussion_id: afe_survivorship
  kind: INTERPRETATION
  status: OPEN
  prompt: What is known about long-term recovery and subsequent pregnancy?
  rationale: 'Selected registry interviews at least one year after AFE found PTSD-consistent symptoms in 16/29 available survivors; this is not a population PTSD diagnosis rate. Seven women reported a later pregnancy: one miscarriage and six uncomplicated term births without recurrence. These small selected observations support follow-up and individualized counseling, not a claim of zero recurrence risk. The Australasian surveillance captured initial management rather than long-term neurologic outcomes.'
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Of 29 survivors available for interview, 2 reported thyroid abnormalities, 1 reported persistent liver dysfunction, and 16 (55.1%) endorsed symptoms consistent with PTSD
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: 'Seven women who experienced either typical or atypical AFE had a subsequent pregnancy: 1 miscarried, and the other 6 had an uncomplicated pregnancy and delivered at term with no recurrence of AFE.'
- discussion_id: afe_mechanical_hypothesis
  kind: CONTROVERSY
  status: OPEN
  prompt: Does fetal material cause collapse through pulmonary microvascular obstruction?
  rationale: Mechanical obstruction was the historical explanation and remains discussed in older pathology accounts. Detection of fetal material does not quantify occlusion or establish causality. The 2026 SMFM statement considers a direct embolic explanation unlikely; the initiating inflammatory trigger remains unresolved. This entry therefore does not assert an established mechanical-obstruction node.
  evidence:
  - reference: PMID:24888909
    reference_title: 'Amniotic fluid embolism: pathophysiology and new strategies for management.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: the fetal materials create physical obstructions in the maternal microvessels in various organs, such as the lung
    explanation: Older review interpretation, not a new quantitative obstruction experiment.
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: OTHER
    quote_role: REVIEW_SYNTHESIS
    snippet: Despite its name, AFE likely has no direct relation to either amniotic fluid or an embolism
notes: Full review uses original primary abstracts and available full texts, regenerated tables, the 2016 research definition, and the corrected 2026 SMFM statement (PMID:42730345). The separately cached full 2016 SMFM guideline URL corresponds to PMID:26987420; full-body excerpts are cited to that generated URL. StatPearls NBK559107 was mined for clinical coverage, with treatment decisions anchored to the newer primary guideline. No matching deep-research report was available. No consistently validated animal model was identified in the cited sources; clinical observations are not represented as experimental models. Selected-registry symptoms with incomplete denominators retain cohort descriptions rather than disease-wide frequency bands. Uterine atony has no precise HPO binding found in the live search. Chest pain, cough, headache, arrhythmia and cerebral infarction are retained as source-supported clinical findings without assigning a uniquely demonstrated causal mediator.
biochemical:
- name: C1 esterase inhibitor activity
  presence: Decreased
  specificity: Not specific or clinically validated for AFE prediction
  notes: A retrospective Japanese registry study measured lower activity in 106 AFE cases than in 88 uncomplicated deliveries and lower values in 21 fatal than 85 nonfatal cases. This is an association, not proof that reduced activity precedes collapse or results from consumption; prognostic utility and replacement efficacy remain unvalidated.
  evidence:
  - reference: PMID:24561565
    reference_title: C1 esterase inhibitor activity in amniotic fluid embolism.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: C1 esterase inhibitor activity levels were significantly lower in amniotic fluid embolism patients (30.0% ± 1.8%) than in control women (62.0% ± 2.0%) (p < 0.0001).
- name: Plasma tissue plasminogen activator antigen
  presence: Increased in the selected AFE-with-DIC cohort
  notes: Antigen was measured by ELISA, not catalytic activity or active free tPA. Higher antigen cannot by itself establish increased secretion or causal mediation of fibrinolysis. The comparison used 27 AFE cases, 12 severe abruption cases and 23 controls with different sampling and clinical contexts.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: AFE had significantly increased tPA and decreased total TAFI levels compared with severe PA and controls
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: We evaluated antigen levels, not activity, for the plasma tPA and total TAFI
- name: Total thrombin-activatable fibrinolysis inhibitor antigen
  presence: Decreased in the selected AFE-with-DIC cohort
  notes: The assay combined TAFI and activated TAFIa antigen; it did not separately quantify active inhibitory function. Reduced total antigen may be associated with fibrinolysis, but causation and the reason for reduction are unresolved.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Since the capture antibody in the ELISA kit used in the present study detects both TAFI and TAFIa antigens according to the manufacturer, we described the amount of TAFI and TAFIa measured together with the kit as total TAFI.
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: AFE had significantly increased tPA and decreased total TAFI levels compared with severe PA and controls
- name: Prothrombin fragment 1+2 and plasmin–antiplasmin complex
  presence: Increased in selected coagulopathic cases
  notes: These complementary markers indicate coagulation and fibrinolytic activation. Their cross-sectional relationship cannot establish which pathway begins first or exclude microvascular thrombosis.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: PF1 + 2 and PIC were markedly increased in both AFE (n = 27) and severe PA (n = 12) compared to controls (n = 23), without significant difference between those disease groups
- name: D-dimer and functional fibrinogen
  presence: Elevated D-dimer with reduced Clauss fibrinogen
  notes: The Japanese cohort measured functional fibrinogen but not antigenic fibrinogen. Increased D-dimer reflects crosslinked fibrin degradation; the design cannot partition consumption, fibrinogenolysis and polymerization inhibition.
  evidence:
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: the very low values of Clauss fibrinogen with elevated D-dimer levels compared to the control group
  - reference: PMID:38168649
    reference_title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: We could not calculate the Clauss fibrinogen/antigenic fibrinogen ratio because our study was not designed to evaluate fibrinogen antigen levels when we started our study.
- name: Circulating inflammatory cytokines
  presence: Markedly increased in an individual fatal case
  notes: In one 2026 reanalysis, IL-6, IL-8 and IL-10 were elevated at admission and diagnosis relative to six healthy term-labor and six healthy nonlabor controls. This was a previously reported case, not a new cohort. Fever after epidural and lack of autopsy limit etiologic certainty; there was no infected or critically ill concurrent control group, independent prediction validation or tested immunotherapy.
  evidence:
  - reference: PMID:41765067
    reference_title: 'A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: 'The present analysis involved two plasma specimens from this patient: (1) an admission sample obtained before the onset of symptoms/diagnosis and (2) a sample collected at the time of AFE diagnosis.'
  - reference: PMID:41765067
    reference_title: 'A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: The admission plasma sample, obtained when the patient appeared completely asymptomatic, showed extraordinary elevations of key inflammatory cytokines relative to women in labor.
    explanation: Single-case observation against six term-labor and six term-not-in-labor controls.
histopathology:
- name: Fetal squamous material in maternal pulmonary vessels
  description: Fetal squames or other amniotic components have been described in maternal pulmonary vessels at autopsy. Presence is neither required nor pathognomonic, and does not demonstrate that mechanical occlusion caused collapse.
  diagnostic: false
  evidence:
  - reference: PMID:25807263
    reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: The presence of squamous cells in the maternal pulmonary artery circulation is no longer considered pathognomonic.
- name: Pulmonary mast-cell degranulation
  description: Extracellular tryptase staining in selected fatal AFE lung series supports local degranulation. These observations do not establish a validated diagnostic test or a causal mediator common to all cases.
  diagnostic: false
  evidence:
  - reference: PMID:25807263
    reference_title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: These studies, therefore, highlight that mast cell degranulation occurs in the lungs of AFE fatal cases, whereas it does not occur in other fatal pregnancies.
    explanation: Review synthesis of selected autopsy series, not proof of specificity across all causes of death.
progression:
- phase: Acute peripartum presentation
  notes: Presentation is usually abrupt during labor or shortly after delivery, but broader surveillance definitions include later and atypical presentations. Cardiopulmonary compromise and coagulopathy may overlap; an obligatory sequential four-stage course is not established.
  evidence:
  - reference: PMID:42730345
    reference_title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: REVIEW_SYNTHESIS
    snippet: Cardiac arrest accompanies many cases of AFE, but not all
  - reference: PMID:26703453
    reference_title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Five women presented 30 min or more after delivery.
- phase: Recovery and sequelae
  notes: Survivors may require prolonged critical care and follow-up for neurologic, other organ and psychological sequelae. Available studies often ascertain only early outcomes; selected survivors with later pregnancies do not define recurrence risk.
  evidence:
  - reference: PMID:33345954
    reference_title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    quote_role: PRIMARY_RESULT
    snippet: Among women who survived either atypical or typical AFE, long-term complications that include medical and psychological manifestations involving depression and post-traumatic stress disorder (PTSD) symptoms, were recorded from those contacted and available for interview at least 1 year post-event.
references:
- reference: PMID:17055946
  title: 'Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study.'
- reference: PMID:21126320
  title: Amniotic fluid embolism in an Australian population-based cohort.
- reference: PMID:24402585
  title: Amniotic fluid embolism.
- reference: PMID:24561565
  title: C1 esterase inhibitor activity in amniotic fluid embolism.
- reference: PMID:24865116
  title: Incidence, diagnosis and pathophysiology of amniotic fluid embolism.
- reference: PMID:24888909
  title: 'Amniotic fluid embolism: pathophysiology and new strategies for management.'
- reference: PMID:25807263
  title: 'Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.'
- reference: PMID:26703453
  title: 'Amniotic fluid embolism: an Australian-New Zealand population-based study.'
- reference: PMID:26987420
  title: 'Amniotic fluid embolism: diagnosis and management.'
- reference: PMID:27372270
  title: Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.
- reference: PMID:28188959
  title: 'Amniotic fluid embolism: Pathophysiology from the perspective of pathology.'
- reference: PMID:30481492
  title: Evaluation of proposed criteria for research reporting of amniotic fluid embolism.
- reference: PMID:31376394
  title: 'Amniotic fluid embolism: principles of early clinical management.'
- reference: PMID:32157417
  title: 'Amniotic fluid embolism-associated coagulopathy: a single-center observational study.'
- reference: PMID:33345954
  title: 'Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.'
- reference: PMID:35840499
  title: Acute respiratory distress and amniotic fluid embolism in pregnancy.
- reference: PMID:38082418
  title: 'Amniotic fluid embolism: a reappraisal.'
- reference: PMID:38168649
  title: Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
- reference: PMID:38219609
  title: 'Amniotic fluid embolism: 20-year incidence and case-fatality trends in the United States.'
- reference: PMID:41765067
  title: 'A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.'
- reference: PMID:42730345
  title: 'Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.'
- reference: url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
  title: https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
- reference: url:https://www.ncbi.nlm.nih.gov/sites/books/NBK559107/
  title: Amniotic Fluid Embolism - StatPearls - NCBI Bookshelf
  tags:
  - StatPearls
📚

References & Deep Research

References

23
PMID:17055946
Amniotic-fluid embolism and medical induction of labour: a retrospective, population-based cohort study.
No top-level findings curated for this source.
PMID:21126320
Amniotic fluid embolism in an Australian population-based cohort.
No top-level findings curated for this source.
PMID:24402585
Amniotic fluid embolism.
No top-level findings curated for this source.
PMID:24561565
C1 esterase inhibitor activity in amniotic fluid embolism.
No top-level findings curated for this source.
PMID:24865116
Incidence, diagnosis and pathophysiology of amniotic fluid embolism.
No top-level findings curated for this source.
PMID:24888909
Amniotic fluid embolism: pathophysiology and new strategies for management.
No top-level findings curated for this source.
PMID:25807263
Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools.
No top-level findings curated for this source.
PMID:26703453
Amniotic fluid embolism: an Australian-New Zealand population-based study.
No top-level findings curated for this source.
PMID:26987420
Amniotic fluid embolism: diagnosis and management.
No top-level findings curated for this source.
PMID:27372270
Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.
No top-level findings curated for this source.
PMID:28188959
Amniotic fluid embolism: Pathophysiology from the perspective of pathology.
No top-level findings curated for this source.
PMID:30481492
Evaluation of proposed criteria for research reporting of amniotic fluid embolism.
No top-level findings curated for this source.
PMID:31376394
Amniotic fluid embolism: principles of early clinical management.
No top-level findings curated for this source.
PMID:32157417
Amniotic fluid embolism-associated coagulopathy: a single-center observational study.
No top-level findings curated for this source.
PMID:33345954
Amniotic fluid embolism syndrome: analysis of the Unites States International Registry.
No top-level findings curated for this source.
PMID:35840499
Acute respiratory distress and amniotic fluid embolism in pregnancy.
No top-level findings curated for this source.
PMID:38082418
Amniotic fluid embolism: a reappraisal.
No top-level findings curated for this source.
PMID:38168649
Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.
No top-level findings curated for this source.
PMID:38219609
Amniotic fluid embolism: 20-year incidence and case-fatality trends in the United States.
No top-level findings curated for this source.
PMID:41765067
A subclinical cytokine storm is present before the clinical diagnosis of amniotic fluid embolism: implications for the prediction and prevention of maternal death.
No top-level findings curated for this source.
PMID:42730345
Society for Maternal-Fetal Medicine Special Statement: Checklist for initial management of amniotic fluid embolism-Updated 2026.
No top-level findings curated for this source.
url:https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
https://assets.noviams.com/novi-file-uploads/smfm/Publications_and_Guidelines/Clinical_Guidelines/CG_9_amniotic_fluid_embolism.pdf
No top-level findings curated for this source.
url:https://www.ncbi.nlm.nih.gov/sites/books/NBK559107/
Amniotic Fluid Embolism - StatPearls - NCBI Bookshelf
No top-level findings curated for this source.